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Investigation of anticancer properties of Philenoptera violacea 





The aim of this study was to assess Philenoptera violacea (Klotzsch) Schrire and 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand as anticancer agents, to 
determine the mutagenic and anti-mutagenic properties, anticancer activity, 
antibacterial and antioxidant activity of these plant extracts, radioprotective effects of 
X.zambesiaca and phytochemical screening of both plant extracts in order for them 
to be used in developing novel anticancer drugs. The extracts of medicinal plants 
were prepared using the maceration with methanol as solvent. Methanol extracts 
were tested for their growth inhibitory effects in vitro using the Sulforhodamine B 
assay. Mutagenic properties were determined by the Ames test, using Salmonella 
typhimurium strains TA98 and TA100 without S9. Antibacterial activity was 
determined using p-Iodonitrotetrazolium chloride assay. The antioxidant activity was 
determined using 2, 2- diphenyl-1-picrylhydrazyl assay. X.zambesiaca and 
P.violacea were classified as inactive (TGI >50 µg/ml) against breast (MCF7), colon 
(HCT116), renal (UACC-62), melanoma (TK-10) and prostate (PC3) cancer cell 
lines. Results of test for the mutagenic properties of P.violacea and X.zambesiaca 
plant extracts revealed that neither plant has mutagenic effects. Antibacterial activity 
results revealed that both plants‘ extracts had no antimicrobial activity against 
Staphylococcus aureus, S. epidermidis, S. saprohyticus, Bacillus subtilis, 
Enterobacter cloacae, Escherichia coli or Pseudomonas aeruginosa. P.violacea 
plant extract showed low antioxidant activity, while X.zambesiaca extract exhibited 
moderate dose-dependent antioxidant activity and can be considered a weak source 
of antioxidant. In view of these antioxidant results, the free radical scavenging ability 
of X.zambesiaca was confirmed by determining the radioprotective effects of this 
extract on human prostate cancer cells (DU145), which were irradiated to 2 Gy. 
Results showed a significant radiation protection effect that can lead to over 50% 
reduction in cell death. Qualitative phytochemical analysis of these plant extracts 
confirmed the presence of tannins, flavonoids, steroids, terpenoids, alkaloids and 
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cardiac glycosides from P.violacea extract, while X.zambesiaca extract showed the 
presence of flavonoids, saponins, terpenoids and glycosides. The gallic acid 
equivalents (GAEs) of the estimated phenolic concentrations ranged from 0.152 ± 
0.0269 to 0.0895 ± 0.006 mg/GAE. Liquid chromatography-mass spectrometry 
analysis of these plant extracts showed the presence of nine compounds (including 
two unknown compounds) from P.violacea, and seven compounds from 
X.zambesiaca. The results thus indicate the possibility of using X.zambesiaca 
(methanol mixture of leaf, twig and flower) extracts as a radioprotector and an 
antioxidant agent to counteract and prevent cell damage by free radicals.  These 
results were encouraging, despite the need for clinical studies to determine the real 
effectiveness and potential toxic effects of this extract in vivo. Our results led us to 
raise questions about the effect of P.violacea (methanol mixture of leaf, twig and 
flower) extracts, which proved to possess a number of active compounds that were 
somehow inactive, regardless of how many times we re-analyzed them. Finally, 
results revealed the importance of X.zambesiaca as a possible anticancer drug. 
 







Historically, plants have been used for a variety of purposes in all human cultures: 
food, culinary spices, medicine, cosmetics, spiritual symbols or aids and ornamental 
plants and are still being used for these reasons. Various but specific plants have 
been used as medicinal agents to treat illnesses since ancient times. Traditional 
medicine, with medicinal plants as the most important component, are sold in 
marketplaces or prescribed by traditional healers in their homes (Von Maydell, 
1996), particularly in the rural areas of South Africa where herbal medicine is the 
main resource of the health care system. South Africa‘s rich plant biodiversity, with 
over 20 000 different species, is a great source of interest to the scientific community 
(Cherry, 2005). Although there is an abundance of plants used as medicine, there 
are specific traditional ways of processing and applying plant-based medications and 
these have been handed down from generation to generation. 
 
According to Pavithra et al. (2010), since 1990s there has been a growing shift in 
interest towards plants as significant sources of new pharmaceuticals and herbalism 
has become mainstream throughout the world. It is estimated that three quarters of 
the world population rely on herbal and traditional medicine as a basis for primary 
health care (Efferth and Kaina, 2011). It was discovered that between 12 and 15 
million South Africans still depend on traditional herbal medicines from as many as 
700 indigenous plant species (Meyer et al., 1996). Up to 60% of the South African 
population consult one of an estimated 200 000 traditional healers, especially in rural 
areas where traditional healers are more numerous and accessible than Western 
doctors (Liu, 2011). Because of this strong dependence on plants as medicines, 
studies are conducted to determine their safety and their efficacy and on the other 
hand to discover new active principles in plants. 
In South Africa and Africa as a whole, the evaluation and recognition of traditional 
medicine aims to improve its availability and wider application at low cost. The 
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introduction of modern medicines and practices (including standardization of doses), 
as well as other socio-economic development processes (such as medical records 
and access to medical aid schemes), can improve the application of traditional 
healing. Plant-derived natural products provide an interesting source for isolating and 
screening potent molecules to combat inflammatory diseases, hypertension and 
cancer. Modern isolation and screening technologies have enhanced the search for 
new lead molecules and increased interest in folk medicinal plant extracts in drug 
companies (Balunas and Kinghorn, 2005).  
Pharmaceutical companies show interest in plant-derived drugs mainly owing to the 
current widespread belief that ‗green medicine‘ is safe, with fewer side effects 
(Pavithra et al., 2010). There are still challenging tasks for scientists working in drug 
research to investigate the efficacy of herbal medicine, to distinguish favorable from 
adverse effects, to identify active principles in medicinal plants, to ban poisonous 
plants or contaminations from herbal mixtures (Efferth and Kaina, 2011) and to 
assess preparations for safety or toxicity to the tissue or organs of mammalian 
recipients. According to Cragg and Newman (2000), over 50% of the drugs in clinical 
trials for anticancer activity were isolated from natural sources. Cardoso et al. (2006) 
demonstrated that some plants used for traditional medicine have in vitro mutagenic 
activity. This has increased awareness about the potential mutagenic hazards 
resulting from long-term use of traditional medicinal plants (Elgorashi et al., 2003).  
Many conventional drugs also induce genetic damage that itself can be carcinogenic. 
As a result, a section of the research community is focusing on identifying novel 
chemotherapeutic agents in plants that do not induce the destructive effects of 
conventional cytotoxic therapeutic agents. As some of the active ingredients are 
potentially toxic, there is a need to evaluate the safety of plant preparations.  
Therefore, traditional plants must be considered potentially unsafe and further testing 
before their continued use, is recommended. The following study is aimed at 
investigating P.violacea and X.zambesiaca as anticancer agents, determining the 
mutagenic and anti-mutagenic properties of the extracts, anticancer activity, 
antibacterial and antioxidant activity of plant extracts and phytochemicals studies of 
the plant extracts to allow them to be used in developing novel anticancer drugs. 
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1.2 LITERATURE REVIEW 
1.2.1 Usage of natural medicinal plants 
Cancer is a highly complex, ubiquitous and devastating disease causing 10 million 
new diagnoses worldwide per annum. Of these, 6.7 million will succumb. At present 
there are 24.6 million cancer patients living with cancer and hoping to survive (WHO, 
2005). It is projected that deaths from cancer will continue to escalate, with an 
estimate of nine million deaths from cancer in 2015 and 11.4 million deaths by 2030 
(WHO, 2005). It is a widely accepted view that cancer starts in just one of the body‘s 
billions of cells and progressively transforms to malignancy in multiple stages 
through sequential acquisition of additional mutations. The immune system of the 
body then fails to respond properly by destroying the cancerous cells. The cancerous 
cells lose their normal controls of cell division and continue to proliferate. The cells 
then divide to form abnormal cells, without normal genetic controls. 
Currently, interest in alternative therapies is increasing as dissatisfaction with 
traditional therapies grows, thus there is marked scientific and commercial interest in 
the continuing discovery of new anticancer agents from natural product sources. The 
search for natural products to be used in cancer therapy represents an area of great 
interest in which the plant kingdom is the most important source, which provides 
many anti-tumor agents with novel structures and unique mechanisms of action 
(Chang et al., 1999). Chemotherapy treatment uses medicine to weaken and destroy 
cancer cells in the body, including cells at the original cancer site. These cells 
develop resistance and are restricted by dose-limiting side effects. The absence of 
markedly improved treatments despite decades of research, the toxicity of 
chemotherapy, cells developing resistance and the lack of significant improvement in 
cure rates for the major cancers contribute to dissatisfaction (DeVita et al., 1991). 
This has led to increasing interest even within the traditional medical community in 
finding alternative cancer treatments. 
Several medicinal plants are traditionally used in the treatment of a variety of 
diseases, including cancer, by the population of South Africa and neighboring 
countries. Since ancient times, herbal medicine has always been one of the main 
components of the health care system. Many conventional drugs induce genetic 
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damage that itself can be carcinogenic. As some of the active ingredients are 
potentially toxic, there is a need to evaluate the safety of plant preparations. A 
segment of the research community is thus focusing on identifying novel 
chemotherapeutic agents in plants that do not induce the destructive effects of 
conventional cytotoxic therapeutic agents. Compounds that are derived from plants 
have contributed significantly in the development of some useful anticancer drugs 
such as taxol, etoposide, vinblastine and vincristine. Plants are potential sources of 
natural antioxidants and produce various antioxidative compounds to counteract 
reactive oxygen species, including free radicals such as superoxide anion radicals 
and hydroxyl radicals (Huda-Faujan et al., 2009). Thus, investigation of traditionally 
used medicinal plants is valuable as a source of potential chemotherapeutic agents 
and to assess the safety of the continuous use of medicinal plants.  
 
1.2.2 Background of the plants under study 
The flowering plant family Fabaceae includes approximately 18 000 species and 400 
genera of flowering, leguminous plants (Brummitt et al., 2007). Trees, herbs, vines 
and shrubs of this plant family are native to all regions of the world and are 
commonly cultivated. Fabaceae is the most common family found in tropical 
rainforests and in dry forests in the Americas and Africa. The genus Xanthocercis 
belongs to the family of Fabaceae and comprises three species,namely X. 
madagascariensis, X. rabiensis, X. zambesiaca. These three species are large, 
evergreen trees that have not been scientifically assessed yet for either efficacy or 
safety to human tissues or organs.  
   
Figure 1.1: X.zambesiaca tree (on the left) and flowers, leaf and twig (on the right) 
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X.zambesiaca is a protected plant in South Africa, grows on alluvial soils and is only 
found in Limpopo and Mpumalanga. This species is known as 
mmchetuchetu/musharo in Shona, nyala berry in English, hoenderspoor or 
njalaboom in Afrikaans, mhota/moladi/motlha in Setswana and mutshato in Vhenda. 
In this study, X.zambesiaca will sometimes be referred to as X.zambesiaca.  
 
   
Figure 1.2: P.violacea tree (on the left) and flowers, leaf and twig (on the right) 
 
P.violacea usually grows near water at low to medium altitudes but not in evergreen 
forests (Isman, 2008). It prefers well-drained soil and the plant is very sensitive to fire 
(Isman, 2008). Fruit is produced from May to October (Palmer and Pitman 1972). 
Medicinally the roots of this plant are used to treat stomach disorders, hookworms 
and coughs. Rotenone, used in the insecticide Derris, is extracted from the roots 
(Isman, 2008). The plants‘ wood is used for making grain mortars and tool handles, 
as it is strong, fairly hard and heavy. Many Africans are superstitious about 
P.violacea, as it is one of the rain trees. In Tanzania the leaves are put into the 
luggage of travelers for protection during a journey. The tree is also known to be a 
reliable indicator of ground water. 
 
Philenoptera is a genus of 12 species belonging to the Fabaceae family and 
Papilionoideae subfamily (Drummond, 1981; Brummitt et al., 2007). P.violacea is 
known also as apple leaf or rain tree in English, appelblaar in Afrikaans, mphata in 
Sotho, mohata in Tsonga and isihomohomo in Zulu. It is a plant species in the 
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legume family (Fabaceae), found in the Democratic Republic of Congo, Tanzania, 
Zambia, northern Namibia, Zimbabwe, South Africa and Swaziland. P.violacea is a 
protected plant in South Africa, mainly found in the northern part of Limpopo and 
Kwazulu-Natal province and in the warmer parts of Mpumalanga and the Eastern 
Cape Province (Schrire, 2000). This species has been used in traditional remedies in 
South Africa. Roots have been used for gastro-intestinal problems, powdered root-
bark for colds and snakebite treatment, root infusions as hookworm remedy and 
most parts of the plant as treatment for diarrhea (Bruschi et al., 2011). According to 
the literature, X.zambesiaca has demonstrated anti-tuberculosis activity and 
antihyperglycemic activity against diabetic mice. Isoflavones have also been 
identified from this plant. However, its anticancer activity has never been 
investigated. The efficacy, safety, toxicity and correct administration dose of the plant 
has not yet been determined, as these plants have never been investigated for 
pharmaceutical use before. In this study P.violacea and X.zambesiaca extracts will 
be analyzed to determine whether these plants can be used to develop novel 
anticancer drugs. 
 
1.3 RESEARCH OBJECTIVES AND OUTCOMES  
Problem statement: Current anticancer drugs yield dissatisfactory results because of 
their toxic side effects and dose dependency. There is a continuous need for cost-
effective cancer therapy protocols that can be approved by national health 
authorities. 
1.3.1 The aim of the study  
The aim of the present research is to investigate the anticancer activity of P.violacea 
and X.zambesiaca plant extracts.  
1.3.2 The objectives of this project are as follows: 
1. To determine the anticancer activity of P.violacea and X.zambesiaca against 
human cell lines. 
2. To determine the mutagenic and anti-mutagenic properties of P.violacea and 
X.zambesiaca extracts. 
3. To determine the antibacterial activity of P.violacea and X.zambesiaca extracts. 
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4. To determine the antioxidant activity of P.violacea and X.zambesiaca extracts. 
5. To determine the active phytochemicals of P.violacea and X.zambesiaca 
extracts. 




(a) Null hypothesis 
(I) P.violacea and X.zambesiaca plant extracts have anticancer activity.  
(II) P.violacea and X.zambesiaca extracts have anti-mutagenic properties. 
(III) P.violacea and X.zambesiaca plant extracts have antibacterial activity. 
(IV) P.violacea and X.zambesiaca plant extracts have antioxidant activity. 
(V) P.violacea and X.zambesiaca plant extracts contain phytochemicals. 
(VI) P.violacea and X.zambesiaca plant extracts contain bioactive compounds. 
 
(b) Alternative hypothesis 
(I) P.violacea and X.zambesiaca plant extracts do not have anticancer activity. 
(II) P.violacea and X.zambesiaca plant extracts do not have anti-mutagenic 
properties. 
(III) P.violacea and X.zambesiaca plant extracts do not have antibacterial activity. 
(IV) P.violacea and X.zambesiaca plant extracts do not have antioxidant activity. 
(V) P.violacea and X.zambesiaca plant extracts do not contain phytochemicals. 




1.4.1 Plant material selection 
The family Fabaceae contains species such as Phaseolus vulgaris L, Glycine max L, 
Vigna unguiculata (Bennink, 2002), Glycyrrhiza glabra (Kainsa et al., 2012) etc., 
which have been reported as useful anticancer agents. These publications resulted 
from a drive to find 60 African plants belonging to the Fabaceae family, in the hope 
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of discovering novel anticancer agents. P.violacea and X.zambesiaca extracts were 
randomly selected from the 60 plants. 
1.4.2 Plant material collection 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa. These two plants were 
chosen from 60 plants belonging to the Fabaceae family. Twigs, leaves and flowers 
of P.violacea and X.zambesiaca were collected and mixed respectively. The 
collected material was dried at room temperature, pulverized by mechanical mills 
and weighed. It was then stored in a cool place until analysis. 
1.4.3 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours, with occasional stirring.  The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol extract was concentrated by using a rotator evaporator. 






















Collection of plant 
material: P.violacea 
and X.zambesiaca 







































Figure 1.3: A diagrammatic summary of steps in the study of the investigation of anticancer 
activity of P.violacea and X.zambesiaca plant extract. 
  
 
1.5 STATISTICAL ANALYSIS 
Tests were carried out in triplicate and data reported as mean ± SD. The data 
obtained from the study were analyzed statistically by analysis of variance (ANOVA) 
using Graph pad prism version 5.0 software. Data from the test groups were 








1.6 STUDY OVERVIEW 
 
Chapter 1 demonstrates the importance of medicinal plants in developing countries. 
The background of the plants investigated in this dissertation is discussed thoroughly 
in this section. The evidence of astounding dependence on traditional medicine has 
already led to the development of drugs derived purely from plants. The chosen 
plants are traditionally used for different alignments/diseases, but their effect against 
cancer has never been explored before. The study objectives are set out to report 
the activity of these plants as anticancer and chemopreventative agents in Chapters 
2-8. Chapter 2 presents the evaluation of the in vitro anticancer activity of both 
plants‘ extracts. Chapter’s 3-5 reports on studies that evaluate the in vitro toxicity of 
the plant extracts and the antibacterial and antioxidant properties of these plant 
extracts. Chapters 6 and 7 focused on the evaluation of active compounds present 
in these methanol plants extracts. Chapter 8 reports on the evaluation of the 
radioprotective effect of one plant that proved to have potential as an antioxidant 
agent. Based on the overall study findings, Chapter 9 and Chapter 10 provide a 
conclusion and recommendations, respectively. 
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“Anticancer activity of P.violacea and X.zambesiaca” 
ABSTRACT 
 
There is marked scientific interest in the continuing discovery of new anticancer 
agents from natural product sources, as current anticancer drugs have many 
negative side effects. Chronic inflammation is a major cause of cancer formation, 
and P.violacea is traditionally used to treat inflammation-related disorders, while 
X.zambesiaca has been demonstrated to have anti-tuberculosis properties. The aim 
of the present study was therefore to determine the anticancer activity of P.violacea 
and X.zambesiaca leaf, twig and flower extracts. Methanol extracts were tested for 
their growth inhibitory effects in vitro against breast (MCF7), colon (HCT116), renal 
(UACC-62), melanoma (TK-10) and prostate (PC3) cancer cell lines using the 
Sulforhodamine B assay. Based on total growth inhibition (TGI) of the cell lines, 
extracts were classified into four categories: inactive, weak, moderate and potent. 
Etoposide and parthenolide were used as positive controls in this assessment. Plant 
twig, leaf and flower mixtures of X.zambesiaca and P.violacea were classified as 
inactive (TGI >50 µg/ml). Results showed that these extracts do not have anticancer 
activity against selected human cancer cell lines, but this does not exclude their 
activity against other cancer cell lines. These plant extracts will be tested further for 














Traditional medicine is widely practiced, especially in African developing countries. 
This is a result of primary health care facilities being unable to manage the number 
of patients requiring aid, as well as the high cost of Western pharmaceuticals and 
health care. It is estimated that between 12 and 15 million South Africans still 
depend on traditional herbal medicines from as many as 700 indigenous plant 
species (Meyer et al., 1996). This great dependence and immense usage of 
traditional plants as the preferred form of health care is aided by the fact that most of 
these plants are widely available and affordable. Natural products have been used 
for the treatment of various diseases since ancient times. Currently, interest in 
alternative therapies is increasing as dissatisfaction with traditional therapies grows, 
thus there is marked scientific and commercial interest in the continuing discovery of 
new anti-cancer agents from natural product sources.  
 
The search for natural products that provide many anti-tumor agents with novel 
structures and unique mechanisms of action is vital (Chang et al., 1999), as the 
current chemotherapy treatments weaken and destroy cancer cells in the body, 
including cells at the original cancer site. However, some cancerous cells develop 
resistance, as the current treatment is restricted by dose-limiting and produces 
unpleasant side effects. The absence of markedly improved treatments despite 
decades of research, the toxicity of chemotherapy, cells developing resistance and 
the lack of significant improvement in cure rates for the major cancers contribute to 
dissatisfaction with the current cancer treatments (DeVita et al., 1991). This has led 
to increasing interest, even in the traditional medical community, in alternative 
cancer treatments. Therefore, this study was conducted to investigate the anticancer 
activity of X.zambesiaca and P.violacea plant extract. 
 
2.2 LITERATURE REVIEW 
 
Cancer can develop in any human tissue subsequent to the loss of normal cell-cycle 
control due to various factors that lead to cellular malfunction. These abnormal cells 
or undifferentiated cells with unregulated growth can proliferate and suppress the 
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growth of normal cells. Studies have revealed that certain cancers are more common 
in people of certain cultures than others. In South Africa, the cancer incidence rates 
among blacks are high for breast, prostate, skin and colon cancer, while cervix, 
esophageal, prostate and breast cancer incidence rates are high among Caucasians 
(Albrecht, 2003). In 1998, 60 172 new cancer cases were reported and 60 343 new 
cases in 1999, of which the ethnic group at highest risk was determined as South 
African Caucasians (Mqoqi et al., 2004). There is a need to discover and develop 
anticancer agents to combat the cancer crisis the world is facing. 
 
Chemoprevention is a process that delays or prevents carcinogenesis in humans 
through the ingestion of dietary or pharmaceutical agents. Most traditional medicines 
used by South Africans are ingested. The searches for anticancer agents from plant 
sources dates back to the time of our forefathers and plant products have been 
proven to be an important source of anticancer drugs (Cragg and Newman, 2005). 
This is because of their biologically and chemically diverse nature, which allows for 
the discovery of completely new chemical classes of compounds. The discovery and 
development of plant-derived compounds with cytotoxic agents that are effective 
against a range of cancer cell lines, while being less active or non-toxic against the 
normal cell population, may lead to the first cures of human cancer. Shishodia and 
Aggarwal (2004) determined that approximately 74% of 90 prescribed anti-cancer 
drugs were developed in response to an investigation into the claims made by 
folkloric tradition. Thus the screening of anticancer activity from plants is determined 




2.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South African (MAS002). The 
collected material was dried at room temperature, pulverized by mechanical mills 
and weighed. It was then stored in a cool place until analysis. 
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2.3.2 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours, with occasional stirring.  The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol extract was concentrated using a rotator evaporator. 
2.3.3 Anticancer screening 
The human cell lines TK10, UACC62 and MCF7 were obtained from the National 
Cancer Institute (NCI) in the framework of a collaborative research programme 
between the Council for Scientific and Industrial Research (CSIR) and the NCI. The 
extracts and compounds were assayed in the three-cell line panel consisting of TK10 
(renal), MCF7 (breast), and UACC62 (melanoma) cancer. Cell lines were routinely 
maintained as monolayer cell cultures at 37°C, 5% CO2 and 100% relative humidity 
in RPMI containing 5% fetal bovine serum, 2 mM L-glutamate and 50 μg/ml 
gentamicin. The primary anticancer assay was performed at the CSIR in accordance 
with the protocol of the Drug Evaluation Branch, NCI (Kuo et al., 1993; Leteurtre et 
al., 1994). The extracts or compounds were tested at a single concentration (100 
ppm) and the culture was incubated for 48 hours. End point determinations were 
made with a protein-binding dye, Sulforhodamine B (SRB). The growth percentage 
was evaluated spectrophotometrically versus controls not treated with test agents. 
Results for each extract were reported as the growth percentage of the treated cells, 
compared to that of the untreated control cells. All the extracts that reduced the 
growth of two of the cell lines by 75% or more were tested further at 1/2 log serial 
dilutions of five concentrations ranging from 6.25-100 ppm. Cells to which no drugs 
were added served as controls. The blanks contained complete medium without 
cells. Etoposide and Parthenolide were used as a standard. Results of five dose 
screenings were reported as TGI (Total growth inhibition). The biological activities 
were separated into four categories: inactive (TGI >50 ppm), weak activity (15 ppm< 









(I) 50% inhibition concentration 
 
IC50 MCF7 HCT116 TK-10 UACC-62 PC3 
P.violacea >100 >100 >100 >100 >100 
X.zambesiaca >100 >100 >100 >100 >100 
Table 2.1. IC50 of methanol extract of P.violacea and X.zambesiaca on five human cell lines: 
MCF7, HCT116, TK-10, UACC-62 and PC3. 
 
Table 2.1 shows the growth inhibitory effects of P. Violacea and X.zambesiaca. Total 




Figure 2.1. Growth inhibitory effect of ethanol extracts of P.violacea on five human cell lines: 
MCF7, HCT116, TK-10, UACC-62 and PC3. 
 
  
Figure 2.2. Growth inhibitory effect of ethanol extracts of X.zambesiaca on five human cell 
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IC50 MCF7 HCT116 PC3 TK-10 UACC-62 
Etoposide <6.25 19.96 34.64 -   - 
Parthenolide <6.25 - - <6.25 <6.25 
Table 2.2. IC50 of Etoposide on three human cell lines (MCF7, HCT116 and PC3) and  
Parthenolide on human cell lines MCF7, TK-10 and UACC-62. 
 
IC50,µg/ml Status 
> 100 µg/ml Inactive 
< 100 µg/ml>15 µg/ml Weak Activity 
< 15 µg/ml> 6.25 
µg/ml Moderate Activity 
< 6.25 µg/ml Potent Activity 
Table 2.3. CSIR criteria 
 
(II) Total growth inhibition 
Activities P.violacea X.zambesiaca P.violacea and X.zambesiaca 
MCF7 HCT116 PC3 
GI50 80.27 78.35 >100 >100 
TGI >100 >100 >100 >100 
LC50 >100 >100 >100 >100 
LC100 >100 >100 >100 >100 
Table 2.4. GI50, TGI, LC50 and LC100 of methanol extract of P.violacea and X.zambesiaca 
on three human cancer cell lines: MCF7, HCT116 and PC3. 
 
TGI, 50 µg/ml Status 
> 50 µg/ml Inactive 
< 50 µg/ml>15 µg/ml Weak Activity 
< 15 µg/ml> 6.25 µg/ml Moderate Activity 
< 6.25 µg/ml Potent Activity 
Table 2.5. CSIR criteria 
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2.5 DISCUSSION  
The sulforhodamine B (SRB) assay is a colorimetric assay that indirectly estimates 
the number of viable cells by staining total cellular proteins. The evaluation of the 
cytotoxicity of P.violacea and X.zambesiaca was investigated using the SRB assay 
to assess the growth inhibition of cells. The ability of P.violacea and X.zambesiaca 
plant extracts to inhibit the in vitro growth of five human cancer cell lines, namely the 
breast (MCF7), colon (HCT116), renal (UACC-62), melanoma (TK-10) and prostate 
(PC3) cancer cell lines, was evaluated. The results were expressed as percentage 
cell growth inhibition at 100 μg/ml, while those indicating a percentage inhibition of 
greater than 80% at 100 μg/ml were expressed as IC50 values. This value is defined 
as the concentration causing 50% cell growth inhibition.  
 
The results of five-dose screening (Table 2.1) were reported as 50% of cell growth 
inhibition (IC50). The biological activities were separated into four categories: inactive 
(IC50 >100 µg/ml), weak activity (15 µg/ml < IC50 <100 µg/ml), moderate activity (6.25 
µg/ml < IC50 <15 µg/ml) and potent activity (IC50 <6.25 µg/ml). According to the CSIR 
criterion (Table 2.3), both samples were considered inactive if parameter IC50 for two 
or all five cell lines was higher than 100 µg/ml.  Therefore both samples can be 
estimated as inactive against the five cell lines, as the parameter IC50 was >100 
µg/ml. Both positive controls in Table 2.2 showed anticancer activity (weak-potent). 
 
The results of five-dose screening were reported as TGI in Table 2.4. The biological 
activities were separated into four categories: inactive (TGI >50 µg/ml), weak activity 
(15 µg/ml < TGI <50 µg/ml), moderate activity (6.25 µg/ml < TGI <15 µg/ml) and 
potent activity (TGI <6.25 µg/ml). For each tested extract, four response parameters 
were calculated: GI50 (50% growth inhibition signifying the growth inhibitory power of 
the test agent), TGI (which is the drug concentration resulting in total growth 
inhibition and signifies the cytostatic effect of the test agent), LC50 (50% lethal 
concentration, signifying the cytotoxic effect of the test agent), LC100 (100% lethal 
concentration, signifying the cytotoxic effect of the test agent). According to the CSIR 
criterion (Table 2.5), both samples were considered inactive if the parameter TGI 
was greater than 50 µg/ml for two or all five cell lines. Therefore both samples can 
be estimated as inactive against five cell lines, as the TGI was >100 µg/ml.  




Both P.violacea and X.zambesiaca extracts can be estimated as inactive (Figures 
2.1 and 2.2) against five selected cell lines. X.zambesiaca has been proven to have 
isoflavones (Harper et al., 1976). This compound regulates estrogen levels. As it is 
known that estrogen reduces the risks of ovarian and endometrial cancer (Narod et 
al., 1998; Greer et al., 2005), anticancer screening on these cell lines might show 
some positive results. Results showed that these extracts do not have anticancer 
activity against selected human cancer cell lines; however, this does not exclude 
their activity against other cancer cell lines such as ovarian and endometrial cancer. 
The results obtained have stimulated us to carry on working to determine their 
anticancer activity against other cell lines. 
 
2.6 CONCLUSION 
Both P.violacea and X.zambesiaca extracts showed no anticancer activity against 
the human cell lines MCF7, HCT116 and PC3. Further testing using other cell lines 
is required, also to identify the active compounds of both P.violacea and 
X.zambesiaca plant extract. 
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“Anti-mutagenic and mutagenic screening of P.violacea and 
X.zambesiaca” 
ABSTRACT 
P.violacea is traditionally used to treat tuberculosis and other inflammation-related 
disorders, while X.zambesiaca is traditionally used to treat diabetes, but these plants‘ 
safety and efficacy have not been investigated. Most plants used as traditional 
medicine have in vitro mutagenic properties, therefore it is important to screen for 
their mutagenic potency. Plants showing clear mutagenic properties are considered 
potentially unsafe and further testing before their continued use is recommended. 
The aim of this study was to investigate the mutagenic and anti-mutagenic properties 
of P.violacea and X.zambesiaca leaves, flower and twig extracts. Mutagenic 
properties were determined by the Ames test using Salmonella typhimurium strains 
TA98 and TA100 without S9. The positive control used was 4-nitroquinoline-1-oxide. 
Results of tests to determine the mutagenic properties of P.violacea and 
X.zambesiaca plant extracts revealed that neither plant has mutagenic effects. 
Based on these results, we therefore concluded that the mutagenicity and 
antimutagenicity effects of P.violacea and X.zambesiaca were observed without the 





Numerous medicinal plants are traditionally used in the treatment of a variety of 
diseases, including cancer or even diseases that contribute to carcinogenesis in the 
African population.  Since ancient times, herbal medicine has been one of the main 
components of the health care system (WHO, 2005). Many conventional drugs also 
induce genetic damage that itself can be carcinogenic. As some of the active 
ingredients are potentially toxic, there is a need to evaluate the safety of plant 
preparations. A segment of the research community is thus focusing on identifying 
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novel chemotherapeutic agents in plants that do not induce the destructive effects of 
conventional cytotoxic therapeutic agents. Compounds that are derived from plants 
have contributed significantly to the development of some useful anticancer drugs 
(Newman and Cragg, 2007). These include taxol, etoposide, vinblastine and 
vincristine. Plants are potential sources of novel anticancer drugs; nevertheless, they 
may sometimes contain toxic and mutagenic compounds.  
 
Several medicinal plants are known to act as mutagenic, co-carcinogenic and/or 
carcinogenic agents. Prevention of cancer and other related diseases can be 
pursued by avoiding exposure to these agents. Previous studies on African 
traditional medicine showed that about 64 plant species used in African traditional 
medicine are potentially mutagenic/carcinogenic, based on their ability to induce 
genetic changes (Schimmer et al., 1988, 1994; Higashimoto et al., 1993; Kassie et 
al., 1996; De Sã Ferrira and Ferrão Vargas, 1999). Although plants used medicinally 
are widely assumed to be safe by their users, the issue of quality control may be 
addressed. P.violacea has traditionally been used to treat gastro-intestinal problems. 
Powdered root-bark has been used for colds and snakebite treatment, root infusions 
as hookworm remedy and most parts of the plant to treat diarrhea (Bruschi et al., 
2011). X.zambesiaca has traditionally been used to treat diabetes mellitus and 
tuberculosis. These plant extracts should consequently be examined carefully for 
their safety perspective and they should be used with caution. This chapter aims to 
report the mutagenic and anti-mutagenic properties of P.violacea and X.zambesiaca 
(leaves, flower and twig mixture) extracts using the in vitro Ames test. 
 
3.2 LITERATURE REVIEW 
 
People have been relying on traditional medicine since ancient times, but as some 
plants are toxic and can be carcinogenic through a process of mutation, there is a 
need to determine the safety of these traditional medicines. Traditional medicine is 
prepared using different parts of the plant, a mixture of plants (infusions); sometimes 
traditional healers just take a bit of this and that without specific measurements. 
Traditional medicine can be described as unsafe until proven safe. People can use 
traditional medicine for years without knowing the toxicity or the damage the 
medicine is doing to them. Some plants may be carcinogenic through three 
© Central University of Technology, Free State
36 
 
manifestations; (1) Directly mutagenic, (2) Promutagenic and (3) Comutagenic 
(Edenharder et al., 1993; Beudot et al., 1998). As it is well known that cancer cells 
are not formed overnight after a single process of mutation, many traditional 
medicine users can be diagnosed with cancer after prolonged usage (Verschaeve et 
al., 2004; Cavalcanti et al., 2006) of traditional medicine.  
 
Cancer is a multistage process that can arise when a normal stem cell acquires two 
or more heritable genetic alterations. Genetic alterations that play an important role 
in human cancers include chromosomal translocation, gene amplification and point 
mutation (Moolgavkar et al., 1999). Within this basic framework, the kinetics of cell 
division and death play a major role in determining the risk of promutagenic lesions, 
spontaneous induction of DNA lesions, genomic rearrangement or loss and 
uncontrolled proliferation of undifferentiated cells. To elaborate further on the risks 
mentioned, fixation of promutagenic lesions occurs when DNA synthesis precedes 
DNA repair, while spontaneous induction of DNA lesions results from errors in DNA 
replication and genomic rearrangement or loss can occur during cell division 
(Hakem, 2008).  Moreover, increased cell division can increase critical target 
populations, unless compensated for by increased differentiation and apoptosis.  
 
Inhibition of apoptosis can influence the process by decreasing the rate of 
elimination of altered, ―initiated‘ cells. According to Moolgavkar et al. (1999), there is 
no universally accepted definition of the terms ―genotoxic‖ and ―nongenotoxic‖. They 
further state that chemicals that increase the rate of genetic alterations by some 
means other than by increasing the rate of cell proliferation, differentiation, or death 
will be considered genotoxic. Chemicals that alter DNA through direct interactions, 
producing point mutation and chromosome damage are therefore treated as 
genotoxic, along with those that, for example, alter DNA repair.  
   
There are good examples of the traditional way to illustrate the initiation stage of 
carcinogenesis (Schins and Hei, 2007), where genotoxic events lead to irreversible 
changes in DNA. Several DNA repair pathways exist but lack of repair or erroneous 
repair may occur especially in a milieu of increased proliferation. DNA damage can 
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also cause cell cycle arrest until the damage is properly repaired. However, DNA 
repair is not flawless and repair may cause mutations.  DNA damage may 
sometimes trigger a pathway that drives that cell towards apoptosis, therefore such 
events may lead to mutations and ultimately to cell transformation (Figure 3.1). 
 
Figure 3.1: DNA damage may cause mutations that may lead to the development of cancer 
(Schins and Hei, 2007) 
 
Compounds from secondary plant metabolism can be beneficial to human beings, 
but some are toxic and have a mutagenic effect (Barnes, 2003) when used by 
human beings. Gómez-Arroyo et al. (2007) demonstrated a high correlation between 
mutagenicity and carcinogenicity. In genetics, a mutagen is a physical or chemical 
agent that changes the genetic material, usually DNA, of an organism and thus 
increases the frequency of mutations above the natural background level. However, 
not all mutations are caused by mutagens: so-called ―spontaneous mutations‖ occur 
owing to spontaneous hydrolysis, errors in DNA replication (Kunkel, 2004; Albertson 
and Preston, 2006), repair and recombination. Some mutagens do not increase the 
frequency of mutation copiously, therefore not all mutagens are carcinogens. The 
Ames mutagenicity test is a short-term bacterial reverse mutation assay specifically 
designed to detect a wide range of chemical materials that can produce genetic 
damage leadng to gene mutations (Griffith et al., 1996). The salmonella test can play 
a central role in a programme of prevention to identify mutagenic chemicals and to 
aid in the development of non-mutagenic products to prevent future human exposure 
(Cann and Ames, 1976). 
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Plants have their own mechanisms of producing secondary metabolites in small to 
large amounts and concentrations vary. Many of these secondary metabolites are 
highly toxic and are often stored in specific vesicles or in vacuoles. Several studies 
undertaken by Kinghorn et al. (2003) and Newman and Cragg (2007) indicate that 
this kind of storage functions on the one hand as a detoxification of the plant itself 
and, on the other hand, it protects the plant against pathogens that are present in the 
soil. The importance of these compounds to plants at large is usually of an ecological 
nature, as they are used as defenses against predators, parasites and diseases. 
Phenolics are used as anti-mutagenic and anti-inflammatory agents because of their 
strong antioxidant properties (Li et al., 2008). Plants with anti-mutagenic potential 
can be considered interesting for therapeutic use and worth further in-depth 
investigation of their pharmacological properties.  
 
Pharmaceutical companies show interest in plant-derived drugs mainly because of 
the current widespread belief that ‗green medicine‘ is safe, with fewer side effects 
(Pavithra et al., 2010). There are still challenging tasks for scientists working in drug 
research to investigate the efficacy of herbal medicine, to distinguish favorable from 
adverse effects, to identify active principles in medicinal plants, to ban poisonous 
plants or contaminations from herbal mixtures (Efferth and Kaina, 2011) and to 
assess plant-derived products for safety or toxicity to the tissue or organs of 
mammalian recipients. According to Cragg and Newman (2000), over 50% of the 
drugs in clinical trials for anticancer activity were isolated from natural sources. Most 
plants used as traditional medicine have in vitro mutagenic properties (Cardoso et 
al., 2006; Mohd-Fuat et al., 2007; De´ ciga-Campos et al., 2007), as a result, it is 
important to screen for their mutagenic potency. Therefore plants with these 
properties must be considered potentially unsafe and further testing before their 
continued use is recommended. This study is aimed at investigating the mutagenic 
and anti-mutagenic properties of P.violacea and X.zambesiaca.  
 





3.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa. The collected material 
was dried at room temperature, pulverized by mechanical mills and weighed. It was 
then stored in a cool place until analysis. 
3.3.2 Sterilisation 
Autoclavable materials such as agar and broth were aseptically sterilized in an 
autoclave at 1210C for 15 minutes. Petri dishes, beakers, McCartney bottles, 
pipettes, test tubes, filter papers and other metal apparatus such as spatulas and 
forceps were sterilized using a hot air oven at a temperature of 1600C for one hour. 
The wire loops were sterilized by heating them on the blue flame of the Bunsen 
burner until red-hot and allowing them to cool and 70% alcohol was used to 
swab/clean the work bench area to prevent contamination. The process was carried 
out aseptically. 
3.3.3 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours, with occasional stirring. The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol solvent was removed completely using a rotator evaporator. 
3.3.4 Preparation of culture media 
All culture media were prepared according to the manufacturers‘ instructions. Agar 
was dissolved by boiling in the microwave and autoclaved at 1210C for 15 minutes.  
 
 




The bacterial strains used for mutagenicity testing were the histidine-requiring 
Salmonella typhimurium tester strains TA98 (detects frameshift mutagens) and 
TA100 (detects mutagens that cause base-pair substitution) without metabolic 
activation.  
3.3.6 Anti-mutagenic and mutagenic screening 
The sample residues were dissolved in DMSO to a known concentration (5000, 500 
and 50 g/ml) prior to biological activity testing. The potential mutagenic effects of 
the investigated extracts were detected using the Ames test. The Ames assay was 
performed with Salmonella typhimurium strains TA98 and TA100 using the plate 
incorporation procedure described by Maron and Ames (1983). Briefly, 100 µL of 
bacterial stock was incubated in 20 ml of Oxoid nutrient for 16 hours at 370C on an 
orbital shaker. The overnight culture (0.1 ml) was added to 2 ml top agar (containing 
traces of biotin and histidine), together with 0.1 ml test solution (test extract, solvent 
control or positive control) and 0.5 ml phosphate buffer (for exposure without 
metabolic activation). The top agar mixture was poured over the surface of the agar 
plate and incubated for 48 hours at 37 °C. After incubation, the number of revertant 
colonies (mutants) was counted. All cultures were made in triplicate (except the 
solvent control where up to five replicates were made) for each assay. The positive 
control used was 4-nitroquinoline-1-oxide (4-NQO) at a concentration of 2 µg/ml.  
 
Figure 3.2: A demonstration of the procedure to count number of revertant colonies 
(mutants) (Gómez-Arroyo et al., 2007) 





Test Sample TA98 TA100 
Number of colonies (revertants) Number of colonies (revertants) 
Concentration (g/ml) Concentration (g/ml) 
5000 500 50 5000 500 50 
P.violacea 34.34.9 43.53.5 33.74.0 211.721.6 143.733.8 152.010.4 
X.zambesiaca 36.34.0 36.76.8 40.02.6 158.38.1 159.712.5 160.31.5 
4NQO (1) 157.3.22.0 355.020.8 
Solvent control 26.62.7 
155.68.3 
 
Table 3.1: No. of his+ revertants in Salmonella typhimurium strains TA98 and TA100 




The Ames assay is commonly used to detect mutagenic and anti-mutagenic 
activities and is a widely accepted method for identifying different chemicals and 
drugs that can cause bacterial reverse mutations. These gene mutations act as hot 
spots for mutagens that cause DNA damage via different mechanisms. When the 
Salmonella tester strains are grown on a minimal media agar plate containing a trace 
of histidine, only those bacteria that revert to histidine independence are able to form 
colonies (Mortelmans and Zeiger, 2000). In this study, we investigated the mutagenic 
and anti-mutagenic activities of P.violacea and X.zambesiaca by the S. 
typhimurium/microsome assay, without addition of an extrinsic metabolic activation 
system (Aicha et al., 2008). The colonies were counted to determine the mutagenic 
and anti-mutagenic potencies of these two plant extracts. 
 
The Ames test is a well-known bacterial mutagenicity test (Weisburger et al., 1996; 
Mortelmans and Zeiger, 2000). In this test, reverse His− →His+ mutations are 
visualized by plating Salmonella typhimurium bacteria in histidine-poor growth 
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mutants that are able to form medium. In this medium only, His+ will able to form 
visible colonies. Different bacterial strains are used to identify different types of 
mutations. In this study, bacterial strains used for mutagenicity testing are the 
histidine-requiring Salmonella typhimurium tester strains and TA100 without 
metabolic activation. Strain TA98 gives an indication of frame-shift mutations, while 
strain TA100 indicates base-pair substitution. For a substance to be considered 
genotoxic in the Ames test, the number of revertant colonies on the plates containing 
the test compounds should be more than twice the number of colonies produced on 
the solvent control plates. In addition, a dose-response should be evident for the 
various concentrations of the mutagen tested.  
 
In the present research, the anti-mutagenicity effect was seen against S. 
typhimurium TA100 and TA98, without the presence of metabolic activation. Based 
on results in chapter 6, the anti-mutagenicity activity of P.violacea and X.zambesiaca 
extracts may be due to the presence of phenolic compounds in these plant extracts. 
Results obtained from the mutagenicity test of P.violacea and X.zambesiaca plants 
are expressed as mean ± S.E.M (Table 3.1) and are based on the number of 
induced revertant colonies. Substances are considered active or mutagenic if the 
number of induced revertant colonies is twice the revertant colonies of the negative 
control (Maron and Ames, 1983). The mutagenic effects of any compound/extract 
are manifested in three ways (Snijman, 2007): (1) Directly mutagenic: Not requiring 
metabolic activation, (2) Promutagenic: Requiring metabolic activation, (3) 
Comutagenic: Enhancing the mutagenic response of a known mutagen irrespective 
of being mutagenic or not. According to our results, neither P.violacea nor 
X.zambesiaca was mutagenic in the salmonella/microsome tester strain TA 100 and 
TA98. However, the risk assessment of these extracts will not be complete unless 




Most plants used as traditional medicine have in vitro mutagenic properties, 
therefore it is important to screen for their mutagenic potency. P.violacea and 
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X.zambesiaca have been used by Africans for the treatment of various diseases for 
centuries. Neither P.violacea nor X.zambesiaca extracts showed any mutagenic 
effect in the salmonella/microsome tester strain TA 100 and TA98 without metabolic 
activation. These plants can be therefore be considered potentially safe, but further 
confirmatory tests are required, such as the determination of cellular toxicity and a 
complete risk assessment of these extracts for promutagenic and comutagenic 
effects. 
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“Antimicrobial activity screening of P.violacea and X.zambesiaca” 
 
ABSTRACT 
Microorganisms‘ involvement in cancer has been identified for over a century, and 
different types of bacteria have been associated with carcinogenesis. Gram-negative 
pathogens, such as Escherichia coli, have been identified as being responsible for 
inflammatory response induction through toxins they secrete. Inflammation is 
considered a new domain in basic and clinical research in patients with prostate 
cancer and benign prostatic hyperplasia. Chronic inflammation is a major cause of 
cancer formation and P.violacea is traditionally used to treat tuberculosis and other 
inflammation-related disorders. The aim of this study was to investigate the 
antimicrobial activity of P.violacea and X.zambesiaca (mixture of leaves, flowers and 
twigs). Antibacterial activity was determined using the p-Iodonitrotetrazolium chloride 
assay on gram-positive bacteria: Staphylococcus aureus, S. epidermidis, S. 
saprohyticus, Bacillus subtilis, and gram-negative bacteria: Enterobacter cloacae, 
Escherichia coli, Pseudomonas aeruginosa. Results of tests for antibacterial activity 
revealed that P.violacea and X.zambesiaca plant extracts had no antimicrobial 




Traditional medicinal practices are used to treat a variety of diseases, including skin 
disorders, tuberculosis, urinary tract infections and gastrointestinal disorders etc. 
(Van Wyk, 2002). Gram-negative pathogens, such as Escherichia coli, have been 
identified in the prostate, and their toxins are responsible for the inflammatory 
response. Inflammation should be considered a new domain in basic and clinical 
research in patients with prostate cancer and benign prostatic hyperplasia (BPH). 
Bacterial infections, urine reflux, dietary factors, hormones and autoimmune 
response have been considered to cause inflammation in the prostate (De Nunzio et 
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al., 2011). From a pathophysiologic point of view, tissue damage associated with 
inflammatory response and subsequent chronic tissue healing may result in the 
development of BPH nodules and proliferative inflammatory atrophy. BPH benefits 
from antibacterial and anti-inflammatory treatment. Staphylococcus aureus could be 
regarded as the first bacterium to be described as a cancer-producing agent, and 
some authors have attempted to associate it with breast cancer (Velázquez et al., 
2010).  
 
African populations suffer chronic diseases whose treatment and follow-up create a 
major economic problem for them (Konkon et al., 2008). Of all the alternative 
modalities, herbal medicine is probably the most popular and the most ubiquitous 
(Akerele, 1993) as it is easily accessible and less expensive. The World Health 
Organization has described traditional herbal medicine as one of the surest means to 
achieve total health care coverage of the world‘s population (Okunlola et al., 2007). 
In traditional herbal practice in Africa, indigenous medicinal plants have been 
employed in the treatment of several important infections (Taylor et al., 2001). 
Interest in medicinal plant research has escalated, with the aim of identifying 
alternative antimicrobial therapies to overcome resistance (Aiyegoro and Okoh, 
2009). Therefore this study was performed with the aim of determining the 
antimicrobial activity of P.violacea and X.zambesiaca plant extracts. 
 
4.2 LITERATURE REVIEW 
 
Microorganism involvement in cancer has been identified for over a century, and 
different types of bacteria have been associated with carcinogenesis. 
Staphylococcus aureus, together with type 16 papillomavirus (HPV-16), has also 
been found in the genome of different bacteria isolated from cervical cancer. 
According to Ma et al. (2009), HPV-16 induces cervical infection that leads to 
cervical cancer and Staphylococcus aureus is used as a vector by this virus. 
Moreover, the inflammatory microenvironment favors the survival and proliferation of 
neoplastic cells (Protti and De, 2012; Li et al., 2012), indicating that the modulation of 
factors fuelling chronic inflammation may have anticancer effects. 
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The ideal chemotherapeutic agent has a high therapeutic index with selective toxicity 
to cause damage to pathogens without causing similar harmful effects to its 
eukaryotic host. This lethal damage to pathogens might be through the inhibition of 
cell wall synthesis, protein synthesis or nucleic acid synthesis, as well as through the 
disruption of the cell membrane and the inhibition of certain essential enzymes. This 
results in selective disruption of the specific structure and/or function essential to 
bacterial growth and survival (Prescott et al., 1996). The efficacy of an antimicrobial 
agent can be estimated through the determination of the minimum inhibitory 
concentration (MIC), being the minimum concentration at which no microbial growth 
occurs after a specified exposure time to the antimicrobial agent (Prescott et al., 
1996). However, there are factors that can influence the efficacy of an antimicrobial 
agent, such as the ability of the drug to reach the target site of infection and the 
susceptibility of the pathogen to the particular chemotherapeutic agent.  
 
Natural products have played a vital role in the discovery of antimicrobial drugs, with 
the drug either being completely derived from the natural product, or serving as a 
lead for novel drug discovery. Plants synthesise a diverse array of compounds 
(secondary metabolites), which play a key role in the natural defence mechanism. 
These aromatic compounds have been found to be useful antimicrobial 
phytochemicals and, as a result, these compounds are now divided into different 
chemical categories: phenolics, terpenoids and essential oils, alkaloids, lectins and 
polypeptides, as well as polyacetylenes (Cowan, 1999). Fluoroquinolones were 
presented as a totally synthetic, significant class of antibiotics in the 1990s (Walsch, 
2000). Some examples of naturally occurring antimicrobials that are currently used 
include drug classes such as the penicillins and cephalosporins (β-lactam being the 
empirically active component). An increase in the isolation and identification of 
antimicrobial compounds may contribute greatly to success in antibiotic discovery. 
 
There are numerous methods for the screening of biological extracts for potential 
antimicrobial activity. The microbroth dilution susceptibility method in 96-well 
microtiter plates has become the preferred method for drug susceptibility testing 
because it has small sample requirements, is cost-effective and has a high 
throughput rate (Pauli et al., 2005). The p-Iodonitrotetrazolium chloride (INT) assay 
is a microplate assay that determines the MIC of biological extracts using INT dye. 
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This dye acts as an electron acceptor and is reduced by viable bacteria to produce a 
colored product. The yellow tetrazolium dye is reduced by viable microorganisms to 
a pink/purple color. The MIC, for the INT assay, is defined as the lowest extract 
concentration that exhibits complete bacterial growth inhibition and prevents the dye 
from changing color (Eloff, 1998).  
 
Plants have been used in the traditional treatment of microbial infections for 
centuries and this knowledge has been passed on from generation to generation. 
The knowledge of indigenous people about plants and their products plays a vital 
role in the health care of a great proportion of the population (Iwu et al., 1999), 
especially in developing countries. One of the most serious threats to the success of 
antimicrobial agents‘ development is the challenge of drug-resistant pathogens, 
resulting from the disproportionate use of antimicrobial agents. Resistance is defined 
as the ability of a microorganism to remain viable and multiply actively under 
conditions that would normally have proved to be inhibitory (Prescott et al., 1996). 
Increased drug resistance may be a result of limited drug diffusion due to the lack of 
or through the overexpression of certain membrane proteins (Cloete, 2003). This 
phenomenon of increased drug resistance, combined with the multiplicity of side 
effects caused by existing agents, makes the search for new antimicrobial agents a 
highly relevant and important subject for research. Hence this study was done to 
determine the antimicrobial activity of P.violacea and X.zambesiaca plant extracts. 
 





4.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa. The collected material 
was dried at room temperature, pulverized by mechanical mills and weighed. It was 
then stored in a cool place until analysis.  
4.3.2 Sterilization 
Autoclavable materials such as agar and broth were aseptically sterilized in an 
autoclave at 1210C for 15 minutes. Petri dishes, beakers, McCartney bottles, 
pipettes, test tubes, filter papers and other metal apparatus such as spatulas and 
forceps were sterilized using a hot air oven at a temperature of 1600C for one hour. 
The wire loops were sterilized by heating them on the blue flame of the Bunsen 
burner until red-hot and allowing them to cool and 70% alcohol was used to 
swab/clean the work bench area to prevent contamination. The process was carried 
out aseptically. 
4.3.3 Extraction method 
Plant extracts were dissolved in DMSO at stock concentrations of 100 mg/mL. 
Working concentrations of 4 mg/mL were prepared in Mueller-Hinton (MH) broth. 
4.3.4 Microorganisms, growth conditions and media  
Staphylococcus aureus, S. epidermidis, S. saprohyticus, Bacillus subtilis, 
Enterobacter cloacae, Escherichia coli and Pseudomonas aeruginosa (clinical 
strains) were grown in MH broth (Merck).  One microorganism colony was inoculated 
in the broth and allowed to grow for 16 hours (log growth phase) at 370C in an orbital 
shaker (150 rpm).  
Control drugs: Imipenem monohydrate (Sigma) and ampicillin sodium salt 
(Calbiochem)/doxycycline hyclate (Sigma) were used as positive controls against 
Gram-negative bacteria and Gram-positive bacteria, respectively.  Antibiotics were 
dissolved in MH broth at stock concentrations of 2 mg/mL and filter-sterilized (0.2 µM 
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filter). Working concentrations of 64 µg/mL imipenem and 16 µg/mL ampicillin and 
doxycyline were prepared in MH broth. 
4.3.5 Microbroth dilution method  
MH broth (50 µL) was added to all test wells (i.e. plant extracts and antibiotics), 
except for the highest plant extract and antibiotic concentration wells, to which 100 
µL of the working concentrations were added.  Serial dilutions were prepared for the 
plant extracts (2 mg/mL to 125 µg/mL) and antibiotic (32-0.125 µg/mL and 8-0.016 
µg/mL for imipenem and ampicillin/doxycycline, respectively).  The cultures were 
assessed and adjusted to a 0.5 McFarland standard (absorbance at 600 nm = 0.08-
0.1; equivalent to ~1.5x108 cells/mL) and 50 µL added to each test well.  The 
following controls were prepared: (i) antibiotic/medium control (50 µL MH broth + 50 
µL of highest antibiotic/fluconazole concentration); (ii) plant extract color control (50 
µL MH broth + 50 µL of highest plant extract concentration); (iii) 2% DMSO control 
(50 µL MH broth + 50 µL 4% DMSO); and (iv) microorganism control (50 µL MH 
broth + 50 µL microorganism).  Plates were sealed with microplate sealing tape and 
incubated at 370C for 24 h.  
P-Iodonitrotetrazolium chloride assay   
After the incubation period, the absorbance of wells was read at 600 nm. 2-(4-
Iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT, Sigma) was 
prepared at a working concentration of 0.2 mg/mL in distilled water and filtered (0.2 
µM filter). INT (20 µL) was added to each well and the plates were further incubated 
for 30-60 min at 370C until there was a color change.  The absorbance of wells was 
read at 600 nm.  Viable cells reduced the yellow dye to a pink/purple color, whereas 
no color change indicated inhibition of bacterial growth. 
 




             
 








































































































































Table 4.1: Microplates template 
control 1 = 50 uL medium and 50 uL 32 ug/mL antibiotic, control 2 = 50 uL medium 
and 50 uL 2 mg/mL extract B; no microorganism (color control), control 3 = 50 uL 
medium and 50 uL 2mg/mL extract C; no microorganism (color control), control 4 = 
50 uL 2% DMSO and 50 uL microorganism, control 5 = 50 uL medium and 50 uL 
microorganism. AB = antibiotic (imipenem); B = P.violacea plant extracts; C= 
X.zambesiaca plant extracts 
 
OD600 nm before INT was added 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A 0.04 0.098 0.409 0.428 0.454 0.415 0.275 0.403 0.438 0.372 0.44 0.371 
B 0.039 0.099 0.408 0.338 0.409 0.512 0.344 0.404 0.387 0.341 0.315 0.403 
C 0.04 0.097 0.46 0.285 0.343 0.328 0.35 0.41 0.362 0.524 0.235 0.33 
D 0.04 0.099 0.427 0.439 0.378 0.402 0.302 0.429 0.365 0.381 0.373 0.326 
E 0.067 0.381 0.389 0.045 0.049 0.047 0.046 0.048 0.047 0.041 0.043 0.042 
F 0.071 0.286 0.346 0.046 0.046 0.047 0.047 0.047 0.046 0.042 0.041 0.049 
G 0.071 0.337 0.363 0.047 0.05 0.046 0.05 0.051 0.047 0.043 0.043 0.042 
H 0.457 0.321 0.405 0.046 0.047 0.047 0.048 0.049 0.048 0.043 0.044 0.042 
 
            
             OD600nm after INT was added 
(~45 min) 
        
             
 
1 2 3 4 5 6 7 8 9 10 11 12 
A 0.04 0.115 0.728 0.747 0.902 0.77 0.601 0.721 0.83 0.715 0.84 0.64 
B 0.04 0.113 0.709 0.635 0.711 1.034 0.525 0.71 0.733 0.726 0.781 0.732 
C 0.042 0.111 0.735 0.683 0.746 0.511 0.589 0.673 0.699 0.763 0.637 0.702 
D 0.041 0.112 0.723 0.605 0.617 0.442 0.429 0.734 0.572 0.585 0.612 0.666 
E 0.076 0.436 0.645 0.048 0.047 0.048 0.054 0.045 0.069 0.042 0.048 0.042 
F 0.078 0.661 0.771 0.047 0.047 0.049 0.059 0.047 0.072 0.065 0.042 0.153 
G 0.082 0.712 0.807 0.05 0.046 0.045 0.06 0.076 0.08 0.048 0.043 0.045 
H 0.494 0.727 0.753 0.048 0.047 0.205 0.106 0.214 0.137 0.06 0.044 0.26 
Table 4.2: OD600 nm readings 




Figure 4.1:  Photos of the INT plates  
 
Microorganism Positive control MIC 
Bacillus subtilis Imipenem 4-8 µg/mL 
Enterobacter cloacae Imipenem 16 µg/mL 
Escherichia coli Imipenem 16-32 µg/mL 
Pseudomonas aeruginosa Imipenem 32 µg/mL 
Staphylococcus aureus Ampicillin/doxycycline 0.5-1 µg/mL 
Staphylococcus 
epidermidis Ampicillin/doxycycline 0.125-2 µg/mL 
Staphylococcus 
saprophyticus Ampicillin/doxycycline 1-2 µg/mL 
Bacillus subtilis Imipenem 4-8 µg/mL 
Table 4.3. MIC values of antibiotics used 
 
Absorbance readings of 96-well plates were taken at a wavelength of 600 nm before 
and after INT addition. The percentage inhibition for the plant extracts was not 
calculated, as there was no observable (Figure 4.1) inhibition of microbial growth. 
For the Gram-positive bacteria (i.e. S. aureus, S. epidermidis and S. saprophyticus) 
imipenem was initially used as a positive control, but it caused complete inhibition 
even at the lowest concentration (0.125 µg/mL).  Ampicillin and doxycyline were 
used to determine MIC values for the Gram-positive bacteria. 





It is known that nonpolar or lipophilic extracts do not easily diffuse into agar. The 
differences in solubility, volatility and diffusion characteristics are among the factors 
that affect the antimicrobial potency of medicinal plant extracts (Cos et al., 2006). 
The microdilution method of quantifying MICs has become the preferred technique 
for evaluating the antibacterial potency of plant extracts or compounds (Cos et al., 
2006). Weak microbial inhibitors are classified as those agents with MIC values 
greater than the ranges listed in Table 1. The antimicrobial activity of P.violacea and 
X.zambesiaca plant extracts was determined using INT assay against selected Gram 
positive and Gram negative bacteria that contribute to carcinogenesis. The sensitivity 
of Staphylococcus aureus, S. epidermidis, S. saprohyticus, Bacillus subtilis, 
Enterobacter cloacae, Escherichia coli and Pseudomonas aeruginosa with respect to 
P.violacea and X.zambesiaca plant extracts was similar, indicating poor antimicrobial 
activity. 
 
X.zambesiaca is traditionally used to treat diabetes mellitus and has been 
scientifically proven to have anti-hyperglycemic effects (Nojima et al., 1998).This 
plant is also used by traditional healers in Limpopo (South Africa) for the treatment of 
symptoms such as wounds, boils, purulent sores and diarrhea (Masoko, 2013). 
Masoko (2013) further reported good antimicrobial activity of leaves of X.zambesiaca 
with methanol, using a microplate serial dilution technique with Staphylococcus 
aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis as 
test organisms. P.violacea is reported to be used in traditional remedies to treat 
gastro-intestinal problems; most parts of the plant have been used to treat diarrhea 
(Mnxati, 2009). Its powdered root-bark is used for colds and snakebite treatment and 
root infusions as hookworm remedy. According to results, neither plant extract 
showed any antimicrobial activity against S. epidermidis, S. saprohyticus, Bacillus 
subtilis or Enterobacter cloacae. In tests conducted by Masoko (2013) against 
bacteria such as Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia 
coli it did not show such activity either.  
However, in our study we mixed different parts of the plant: leaves, twigs and 
flowers. There is a possibility that other compounds from twig and flowers might 
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suppress the activity of active antimicrobial compounds from the leaves of our plant 
extracts instead of having a synergetic effect. A number of factors might contribute to 
these outcomes, such as the area where the plants are collected and climate 
changes. Another factor might be the preparation of extracts by traditional healers, 
as they sometimes prepare extracts using more than one plant and there is no 
systematic approach in doing that. The solvent used to prepare the extract also 
affected our results, as traditional healers use other solvents, such as water, and 








Figure 4.2: The comparative structural complexity of the outer membranes and cell walls of 
Gram-negative and Gram-positive bacteria (Denyer and Maillard, 2002) 
Resistance may also be strengthened by additional resistance mechanisms used by 
the microorganism, such as decreased accumulation of the antimicrobial agent 
within the cell (Denyer and Maillard, 2002). Many harmful agents, including 
antibiotics, are either hydrophobic or relatively large hydrophilic compounds and are 
thus hardly able to penetrate the outer membrane, which must also have an effect. 
This is as a result of the structure of the bacterial cell wall (Figure 4.2), with the 
addition of higher lipid content for Gram negative bacteria (Linfield et al., 1982). 
Interactions of lipophilic compounds with hydrophilic parts of the membrane will bring 
about a more toxic effect against the micro-organism (Sikkema et al., 1995).  
 
It has also been suggested that the polysaccharide constituents of the outer 
membrane aid the bacterial cell in evasion of phagocytosis and protect the deeper 
parts of the outer membrane from complement and antibody binding (Vaara, 1992). 
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In comparison, Gram-positive bacteria possess a much thicker peptidoglycan layer, 
which does not act as an effective barrier to permeation, and inhibitors are thus able 
to pass through more easily (Scherrer and Gerhardt, 1971). However, neither Gram-
negative nor Gram-positive bacteria displayed any sensitivity to the extracts, while 
controls showed positive results. These results were not expected, as it had been 
reported previously that X.zambesiaca leaves had antimicrobial activity against 





P.violacea and X.zambesiaca showed no antimicrobial activity against S. 
epidermidis, S. saprohyticus, B. subtilis, E. cloacae, P. aeruginosa, S. aureus and E. 
coli. From our findings, we could not support the ethnobotanical uses of these plants 
as reported by traditional healers. However, factors that might have contributed to 
these results are not excluded. 
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“Antioxidant activity screening of P.violacea and X.zambesiaca” 
 
ABSTRACT 
Free radicals are important mediators that provoke inflammatory processes and are 
neutralized by antioxidants, which exert an anti-inflammatory effect. Free radical 
scavenging molecules such as flavonoids, tannins, alkaloids and other metabolites 
possess anti-inflammatory, anti-carcinogenic, antibacterial and antiviral properties. 
The aim of this study was to investigate the antioxidant activities of P.violacea and 
X.zambesiaca leaf, flower and twig extracts. These two plants were chosen from 60 
plants found in Africa belonging to the Fabaceae family. The antioxidant activity was 
determined using 2, 2- diphenyl-1-picrylhydrazyl assay. The scavenging activity of 
the X.zambesiaca extract was compared with that of P.violacea and standard 
antioxidant (ascorbic acid). X.zambesiaca showed moderate (50%) free radical 
scavenging activity, while P.violacea extract had low free radical scavenging activity 
at a concentration of 2.5 mg/ml when compared to ascorbic acid. Our results indicate 
that P.violacea plant extract has low antioxidant activity, while X.zambesiaca extract 
exhibits moderate dose-dependent antioxidant activity and can be considered as a 




Oxygen is important for life processes to occur, but an excess of oxygen could result 
in oxidative damage, which may even lead to cell DNA damage. The damage is not 
due to the presence of oxygen, but rather to its role in the reduction of certain 
products to toxic free radicals. These free radicals are produced in living cells and 
are therefore part of the cell‘s normal metabolic processes, including detoxification 
processes and immune system defenses when reactive oxygen species (ROS) living 
independently within the body disrupt normal cell structure and alter the DNA of the 
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cell, which leads to cell malfunction (Kerr et al., 1994). This cellular malfunction may 
lead to uncontrolled proliferation of abnormal cells.   
 
The excessive generation of free radicals, ROS, such as superoxide anions, 
hydroxyl radicals and hydrogen peroxide, contributes to the development of various 
diseases. Diseases such as cancer, rheumatoid arthritis, certain neurodegenerative 
diseases and tissue damage will result and ageing will take place, especially if free 
radical production exceeds the capacity of tissues to remove these ROS radicals 
(Larkins, 1999). It is also known that in a situation of oxidative stress, ROS radicals 
can stimulate the release of cytokines and chemokines that drive recruitment and 
activation of additional inflammatory cells, including activated neutrophils and 
macrophages, and these play an important role in the pathogenesis of cancer 
(Auroma, 1998; Michael et al., 2006). 
 
People have been relying on plants as a source of treatment for various diseases 
and that happens even today, especially in rural areas where traditional healers 
outnumber western doctors. Most medicine used by western doctors is also derived 
from plants. Free radicals are important mediators that provoke inflammatory 
processes and are neutralized by antioxidants that exert an anti-inflammatory effect 
(Filomena et al., 2008). Free radical scavenging molecules such as flavonoids, 
tannins, alkaloids, quinones, amines, vitamins and other metabolites possess anti-
inflammatory, anti-carcinogenic, antibacterial and antiviral activities (Sala et al., 
2002). Plants with antioxidant properties are used for minimizing the severity of 
inflammation-related diseases and a health-promoting effect of antioxidants from 
plants is thought to arise from their protective effects by counteracting ROS (Wong et 
al., 2006). Thus the aim of the study was to determine the antioxidant activity of 
P.violacea and X.zambesiaca plant extract. 
 
5.2 LITERATURE REVIEW 
 
The defense system against free radicals is provided by free radical scavengers that 
act as antioxidants. Free radical scavengers function by donating an electron to the 
free radical, which pairs with the unpaired electron and thereby stabilizes it. These 
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antioxidants may remove catalytic metal ions, remove ROS such as O2-, scavenge 
initiating radicals such as OH- and rearrange electrons that produce oxygen very 
rapidly (Gutteridge, 1994). Antioxidant defense involves both enzymatic 
mechanisms, which utilise specific enzymes such as superoxide dismutase, catalase 
and glutathione peroxidase, and non-enzymatic mechanisms, which utilise nutrients 
and minerals (Aggarwal et al., 2005). 
 
 
Figure 5.1: Diagram illustrating the formation of free radicals from the environment 
(Zander, 2013) 
 
An antioxidant defense mechanism is crucial to survival and can operate at different 
levels within the cells through the prevention of radical formation, interception of 
formed radicals and recognition of excessively damaged molecules. These errors 
are not repaired but rather eliminated to prevent mutations from occurring during 
replication (Kerr et al., 1994). Non-enzymatic antioxidants are classified as either 
water-soluble or lipid-soluble, depending on whether they act primarily in the 
aqueous phase or in the lipophilic region of the cell membranes. The hydrophilic 
antioxidants include vitamin C (ascorbic acid) and certain polyphenol flavonoid 
groups, while the lipophilic antioxidants include ubiquinols, retinoids, carotenoids, 
apocynin, procyanidins, certain polyphenol flavonoid groups and tocopherols 
(Middleton et al., 2000).  
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Antioxidant properties produced by plant species have a full range of applications in 
human healthcare, as they protect against free radicals. Knowledge of the potential 
antioxidant compounds present in a plant species does not necessarily indicate its 
antioxidant capacity, as the total antioxidant effect may be greater than the individual 
antioxidant activity of one compound, owing to synergism between different 
antioxidant compounds in the same plant. In search of sources of novel antioxidants 
with low toxicity, medicinal plants have over the past few years been studied 
extensively for their radical scavenging activity (Molyneux, 2004). As plants produce 
a large number of antioxidants to control the oxidative stress caused by sunbeams 
and oxygen, it is clear that plants may represent a source of new compounds with 
antioxidant activity (Scartezzini and Speroni, 2000). Therefore, in this study, the 




5.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa (MAS002). The 
collected material was dried at room temperature, pulverized by mechanical mills 
and weighed. It was then stored in a cool place until analysis. 
5.3.2 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours with occasional stirring.  The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol extract was concentrated using a rotator evaporator. 
 
5.3.3 Antioxidant activity screening  
 
Scavenging ability towards 1, 1-Diphenyl Picrylhydrazyl (DPPH) radical 
The DPPH assay will be performed as described by Shirwaikar et al. (2006) to 
estimate the free radical scavenging properties of different plant extracts. This 
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method depends on the reduction of purple DPPH radicals to yellow-colored 
diphenylpicrylhydrazine and the remaining DPPH radicals, which show maximum 
absorption at 517 nm, will be measured. An amount of 100 µl of various 
concentrations of each sample will be added to 2 ml solution of 0.1 mM DPPH. As 
control, 100 µl of methanol and 2 ml DPPH will be used. After 60 min of incubation at 
250C in the dark, the absorbance will be recorded at 517 nm. The experiment will be 
performed in triplicate. The DPPH radical scavenging activity will be calculated 
according to the following equation: 
% DPPH radical scavenging activity = 1 - [Asample/Acontrol] x 100 
where Asample and Acontrol are absorbance of the sample and control. Ascorbic 
acid will be used as a standard. The SC50 (concentration of sample required to 
scavenge 50% of DPPH radicals) values will be determined. The decrease of 





























2.5 19.8 0.762±0.012 50.0 0.475±0.00
2 
97.6 0.013±0.001 
1.25 11.8 0.838±0.010 45.3 0.52±0.001 97.2 0.016±0.001 
0.625 7.4 0.880±0.006 44.1 0.531±0.00
1 
96.6 0.019±0.003 
0.313 4.6 0.907±0.021 43.0 0.542±0.00
7 
68.5 0.173±0.007 
0.156 1.2 0.939±0.004 42.8 0.544±0.00
5 
19.2 0.444±0.006 
Table 5.1: In vitro anti-oxidant activity (mg/ml) of P.violacea, X.zambesiaca extracts 
as shown by the DPPH assay. Results are represented as mean ± standard 
deviation, n=3. 






Figure 5.2: % Scavenging activity P.violacea and X.zambesiaca extracts versus 
their concentrations in mg/ml 
 
 
Figure 5.3: Δ Absorbance @ 517 nm wavelength of P.violacea and X.zambesiaca 
extracts versus their concentrations in mg/ml. 
 
5.5 DISCUSSION 
In normal conditions, the human body possesses many defense mechanisms 
against oxidative stress, including antioxidant enzymes and non-enzymatic 
compounds. The natural antioxidant mammalian mechanism sometimes becomes 
insufficient and then the excess of free radicals can damage both the structure and 
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function of a cell membrane in a chain reaction, leading to many degenerative 
diseases (Atta-ur-Rahman and Choudhary, 2001). Antioxidants reduce oxidative 
stress in cells and are therefore useful in the treatment of many human diseases, 
including cancer, cardiovascular diseases and inflammatory diseases. Plants are a 
cheap source for the extraction of antioxidant compounds, thus having an important 
economic advantage. 
The principle of the DPPH assay was based on the hydrogen-donating capacity of 
the test sample. In the DPPH test, the antioxidants reduce the DPPH radical to a 
yellow-colored compound, diphenylpicrylhydrazine, and the extent of the reaction 
depends on the hydrogen-donating ability of the antioxidants (Figure 5.4). DPPH was 
reduced by the donated hydrogen, changing color from deep purple to yellow by the 
standard. The absorption of the deep violet DPPH solution was measured at 517 nm, 
after which absorption decreased because of decolorisation to a yellow color, in the 
event of reduction. This decrease in absorption was stoichiometric according to the 
degree of reduction (Figure 5.3). The remaining DPPH absorbance was measured at 
a time interval of 60 min after the addition of the DPPH, which corresponded 
inversely with the radical scavenging activity of the sample extract or antioxidant 
activity.  
 
Figure 5.4: Diagrammatic representation of chemical reaction of the reduction of 
DPPH in the presence of an electron-donating anti-oxidant (Shirwaikar et al., 2006). 
The methanol extract of both P.violacea and X.zambesiaca demonstrated 
concentration-dependent scavenging activity by quenching DPPH radicals (Figure 
5.1). The free radical scavenging activities of P.violacea and X.zambesiaca extracts 
were observed and compared with the scavenging activity of ascorbic acid in table 
5.1. Ascorbic acid showed high activity with SC50 (68.5%) from a concentration of 
DPPH relatively stable organic 
radical (deep violet colour) 
DPPH is reduced in the presence 
of antioxidant (yellow colour) 
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0.313 mg/ml. The free radical scavenging activity of P.violacea (19.8%) showed 
scavenging activity lower than 50% at a high concentration of 2.5 mg/ml. 
X.zambesiaca extract‘s scavenging activity of 50% was at a concentration of 2.5 
mg/ml. P values were determined using the two-tailed test, and for both extracts 
were p < 0.05, thus statistically significant in P.violacea (p= 0.0010) and 
X.zambesiaca (p= 0.0011). Our results indicate that P.violacea plant extract has low 
antioxidant activity, while X.zambesiaca extract exhibits moderate dose-dependent 
antioxidant activity and can be considered a weak source of antioxidant.  
5.6 CONCLUSION 
 
P.violacea and X.zambesiaca demonstrated dose-dependent free radical scavenging 
activity. The former has low antioxidant potential and the latter has moderate 
antioxidant activity potential. 
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“Phytochemical analysis of P.violacea and X.zambesiaca” 
 
ABSTRACT 
Most medicine used by western doctors is derived from plants. Phytochemicals or 
secondary metabolites are chemical compounds formed during the plants‘ normal 
metabolic processes and plants use them to protect themselves.. Most 
phytochemicals have properties that can protect human cells against oxidative 
damage. The aim of this study was to investigate the phytochemical constituents and 
total phenolic content of P.violacea and X.zambesiaca leaf, flower and twig extracts 
with colometric assays. The estimated total phenol content values of P.violacea and 
X.zambesiaca extracts were analyzed at 1 mg/ml against gallic acid using Folin and 
Ciocalteu‘s phenol reagent. P.violacea extracts showed more polyphenols than 
X.zambesiaca. Qualitative phytochemical analysis of these plant extracts confirmed 
the presence of tannins, flavonoids, steroids, terpenoids, alkaloids and cardiac 
glycosides from P.violacea extract, while X.zambesiaca extract showed the presence 
of flavonoids, saponins, terpenoids and glycosides. The gallic acid equivalents 
(GAEs) of the estimated phenolic concentrations ranged from 0.152 ± 0.0269 to 
0.0895 ± 0.006 mg/GAE. Our results indicate that P.violacea extract has a number of 
phytochemical compounds when compared to X.zambesiaca. Future study will be 




Phytochemicals are bioactive chemicals of plant origin that are formed during the 
plants‘ normal metabolic processes and plants use them to protect themselves 
(Watson et al., 2001; Ning et al., 2009). They are regarded as secondary metabolites 
because the plants that manufacture them may have little need for them. They are 
naturally synthesized in all parts of the plant body: bark, leaves, stem, roots, flowers, 
fruits and seeds, therefore any part of the plant body may contain active components 
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(Tiwari et al., 2011). The quantity and quality of phytochemicals present in plant 
parts may differ from one part to another. In fact, there is still a lack of information on 
the distribution of the biological activity in different plant parts essentially related to 
the difference in distribution of active compounds (or active principles), which are 
more common in some plant parts than in others (Lahlou, 2004). 
Medicinal plants are of great importance to the health of individuals and communities 
in general. The value of medicinal plants lies in chemical substances that produce a 
certain physiological action on the human body. Many indigenous medicinal plants 
are added to food meant for pregnant women and nursing mothers for medicinal 
purposes, as reported by Okwu (1999, 2001) and Hill (1952). The most important 
bioactive constituents of plants beneficial to humankind are alkaloids, tannins, 
flavonoids and phenolic compounds. There is therefore a need to look inwards to 
search for herbal medicinal plants with the aim of identifying, isolating and 
characterizing compounds that will be added to the potential list of drugs. This study 
was aimed at identifying biological compounds from P.violacea and X.zambesiaca 
plant extract. 
 
6.2 LITERATURE REVIEW 
 
It is known that natural products are an excellent source of compounds with a wide 
variety of biological activities. A number of mechanisms exist by which 
phytochemicals aid in the prevention of cancer. These mechanisms of phytochemical 
chemo-preventive agents are categorized into two basic groups, namely blocking 
agents and suppressing agents (Ugbogu et al., 2013). The preventative action most 
probably results from the additive or synergistic effects of a number of 
phytochemicals present in a particular part of the plant. Since cancer is a multi-step 
process, phytochemicals‘ chemo-preventive mechanism may include anti-oxidant 
and free radical scavenging activity, antiproliferative activity, cell-cycle arresting 
activity, induction of apoptosis, activity as enzyme cofactors; (vi) enzyme inhibition; 
(vii) gene regulation; (viii) activity as hepatic phase I enzyme inducers and (ix) 
activity as hepatic phase II enzyme inducers (Manson et al., 2000; Juge et al., 2007; 
Surh, 2003). 




Compounds such as flavonoids are found in a wide variety of plant extracts, fruit and 
vegetables, beverages and herbs.  Flavonoids are a group of polyphenolic 
secondary metabolites with a large number of biochemical and pharmacological 
properties, including cancer-preventative effects (Williams and Grayer, 2004). 
Biochemical interferences produced by flavonoids are associated with their capacity 
to control cell growth. A number of mechanisms by which flavonoids are able to 
prevent carcinogenesis have been reported. These mechanisms include their free 
radical scavenging ability, the modification of enzymes to activate or detoxify 
carcinogens and the inhibition of the induction of the transcription factor activator 
protein activity by tumor promoters (Canivence-Lavier et al., 1996; Shih et al., 2000; 
Moon et al., 2006). Flavonoids have the ability to interfere with the different steps of 
the formation of benign tumor cells that may progress to malignant tumors, as 









Figure 6.1: Flavonoids blocking and suppressing multi-stage carcinogenesis. (Moon 
et al., 2006) 
Bioactive compounds in medicinal plants  
Plants have their own mechanisms of producing secondary metabolites in small to 
large amounts and concentrations vary. Van Wyk and Wink (2004) reported that 
there are generally three major groups of secondary metabolites, namely nitrogen-
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containing compounds (e.g. alkaloids, and terpenoids), phenolics (e.g. flavonoids 
and tannins) and glycosides.  
Alkaloids are well known for potent pharmacological activities in analgesics, anti-
malarial medication, anti-spasmodics and products for the treatment of hypertension, 
mental disorders and tumors (Rajnikant, 2005). Humans have found numerous uses 
for plant alkaloids, from medicinal (pain relievers, tranquilizers, stimulants, muscle 
paralyzers) to agricultural (pesticides and herbicides). Some common examples of 
plant alkaloids include caffeine and cocaine (Robins, 1994). Previous studies 
indicate that alkaloids have antitumor potential and among other characteristics have 
shown in vivo activity against various human viruses (Duri et al., 1994; Hutchings et 
al., 1996). Fig.6.2 shows the chemical structure of a typical alkaloid with the basic 





Figure 6.2. The chemical structure of ephedrine, a phenethylamine alkaloid 
(Wikipedia, 2014< http://en.wikipedia.org/wiki/Phenols>).  
Terpenoids are toxins and feeding deterrents to many plant-feeding insects and 
mammals (Taiz and Zeiger, 2002). Many terpenoids play important roles as plant 
hormones and in the chemical defenses of plants against microbial diseases and 
insect herbivores (Croteau, 1998). They are reported to have medicinal properties 
such as anti-carcinogenic, anti-malaria, anti-ulcer, antimicrobial and diuretic activity 
(Aharoni et al., 2005). Previous studies reported that plants with terpenes possessed 
strong antimicrobial activity (Marin et al., 2001; Ahmed et al., 2005). Figure 6.3 











Figure 6.3. Chemical structure of the isopentenyl pyrophosphate, a terpenoid 
(Wikipedia, 2014< http://en.wikipedia.org/wiki/Phenols>).  
Flavonoids are naturally occurring polyphenolic compounds containing two benzene 
rings linked together with a pyrone ring in the case of flavones or a dihydropyrone 
ring in the case of flavanones (Giuseppe et al., 2007). Flavonoids are normal 
constituents of the human diet and are responsible for a variety of biological 
activities. Some of these act as enzyme inhibitors and antioxidants, and have been 
reported to have anti-inflammatory properties (Middleton et al., 2000). However, the 
molecular mechanisms explaining how flavonoids suppress the inflammatory 
response are still being elucidated (Havsteen, 2002). A few studies have shown that 
certain flavonoids down-regulate NO2 mediators of inflammation production in 
response to inflammatory stimuli (Liang et al., 1999; Kim et al., 2001) but no more 
precise mechanisms of action are known yet. Flavonoids have long been recognized 
as possessing antiallergenic, anti-inflammatory, antiviral, antiproliferative and 
antioxidative activities (Robards et al., 1999). 
Flavonoids are water-soluble phenolic molecules containing 15 carbon atoms and 
are a group of low molecular weight chemical compounds, among others the 
phenylbenzopyrones, found in all vascular plants. They are common constituents of 
fruit, vegetables, nuts, seeds, stems, flowers, tea, wine and honey (Grange and 
Davey, 1990). The physiologically active constituents have been used to treat human 
diseases (Cushnie and Lamb, 2005). These constituents have been reported to 
possess many useful medicinal properties, including anti-inflammatory activity, 
estrogenic activity, enzyme inhibition, antimicrobial activity (Havsteen, 1983), anti-
allergic activity (Harborne and Baxter, 1999), antioxidant activity (Middleton and 
Chithan, 1993), vascular activity and cytotoxic antitumor activity (Harborne and 
Williams, 2000). Some of the recognized activities of flavonoids include anti-allergic, 
anti-cancer, antioxidant, anti-inflammatory, anti-viral and many health-promoting 
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effects (Harborne, 1996). Figure 6.4 shows the chemical structure of a typical 





Figure 6.4. The chemical structure of luteolin, a flavonoid (Wikipedia, 2014< 
http://en.wikipedia.org/wiki/Phenols>).  
Tannins are a complex group of plant secondary metabolites that are soluble in polar 
solutions and are distinguished from other polyphenolic compounds by their ability to 
precipitate proteins (Silanikove et al., 2001). The amount and type of tannins 
synthesized by plants vary considerably, depending on plant species, cultivars, 
tissues, stage of development and environmental conditions (Cornell, 2000). Plant 
parts containing tannins include the bark, woody part, fruit, fruit pods, leaves, roots 
and plant galls. These secondary metabolites are evenly distributed in all leaf 
tissues. Plants containing more than 10% tannins may have potentially adverse 
effects on humans, including upset stomachs, renal damage, hepatic necrosis and 
increased risk of esophageal and nasal cancer (Kemper, 1999). Figure 6.5 shows 





Figure 6.5. Chemical structure of gallic acid, a tannin (Wikipedia, 2014< 
http://en.wikipedia.org/wiki/Phenols>). 
Phenolic acids are a large and heterogeneous group of biologically active non-
nutrients. They are present in plants as hydroxylated derivatives of benzoic and 
cinnamic acids (Havsteen, 1983; Shahidi and Naczk, 1995). Phenolic compounds 
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are important in the defense mechanisms of plants under different environmental 
stress conditions such as wounding, infection and excessive light or ultraviolet 
irradiation (Dixon and Paiva, 1995). Phenolics are not only unsavory or poisonous, 
but also of possible pharmacological value (Strack, 1997). Hydroxybenzoic acids 
have a general structure derived directly from benzoic acid and variations in the 
structures of individual hydroxybenzoic acids lie in the hydroxylations and 
methylations of the aromatic ring (Macheix et al., 1990). Phytochemicals are 
inexpensive, effective, readily applicable and accessible bioactive compounds that 
neutralize free radicals causing cell damage. The inherent potential of these 
phytochemicals in the chemoprevention of cancer cannot be overemphasized, 
especially considering their robust safety records when compared with conventional 
anti-cancer therapies. Phytochemicals are directly responsible for different activities 
such as antioxidant, antimicrobial, antifungal and anticancer ones (Kokate, 1997; 
Harborne, 1998; Hossain and Nagooru, 2011). This has extended the field of 
research for potential anticancer compounds, as some derived anticancer 
compounds are already extensively used, such as etoposide, teniposide, vinblastine 
and vincristine (Lee, 1999; Mans et al., 2000). Thus, the aim of this study was to 




6.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa (MAS002). The 
collected material was dried at room temperature, pulverized by mechanical mills 
and weighed. It was then stored in a cool place until analysis. 
6.3.2 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours, with occasional stirring.  The extracts were filtered and new 
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solvent was added again for more extraction until the solvent remained clear. The 
methanol extract was concentrated using a rotator evaporator. 
6.3.3 Phytochemical analysis 
The extracts were subjected to preliminary phytochemical screening according to 
Okwu (2005). 
I. Test for tannis  
0.2 ml of extract was added to a few drops of 1% FeCI3. A resulting green/blue-
black color indicated the presence of tannins.  
II. Test for flavonoids  
0.1 ml extract was added to 5 ml ammonium hydroxide solution and 3 drops of 
H2SO4. The formation of a yellow color solution and a white precipitate indicated 
the presence of flavonoids.  
III. Test for saponins 
0.1 ml extract was shaken vigorously in 3 ml of water. Foam formation indicated 
the presence of saponins. 
IV. Test for steroids  
To 2 ml of the extract, 2 ml of chloroform and 2 ml of concentrated H2SO4 were 
added and then the solution was shaken well. The presence of steroids is 
indicated by the chloroform (upper) layer turning reddish and the acid layer 
showing a yellow color with greenish fluorescence.  
V. Test for terpenoids  
1 ml of extract was mixed with 2 ml of chloroform and 2 ml H2SO4 was carefully 
added to form a layer. A yellow layer at the interface indicated presence of 
terpenoids.  
VI. Test for alkaloids  
Exactly 0.1 ml extract was added to 1 ml of Mayer‘s reagent. The solution turning 
creamy was indicative of the presence of alkaloids. 
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VII. Test for cardiac glycosides  
In a test tube, 5 ml of the extract was mixed with 2 ml glacial acetic acid, 1 drop 
of 5% FeCI3 and 1 ml concentrated H2SO4. Formation of a brown ring at the 
interface indicated the de-oxysugar characteristic of cardenolides. A violet ring 
may appear below the brown ring, while in the acetic acid layer, a greenish ring 
may form gradually throughout the thin layer.  
VIII. Determination of total phenolic content  
Total phenols content in the extracts obtained were estimated by a colorimetric 
assay based on procedures described by Singleton and Rossi (1965) with some 
modifications. Briefly, 1 mL of sample was mixed with 1 mL of folin and 
Ciocalteu‘s phenol reagent. After 3 min, 1 mL of saturated sodium carbonate 
solution was added to the mixture and adjusted to 10 mL with distilled water. The 
reaction was kept in the dark for 90 min, after which the absorbance was read at 
725 nm wavelength. Gallic acid was used for constructing the standard curve. 





Phytochemical test A B 
Tannins + -- 
Flavonoids + + 
Saponins -- + 
Steroids + -- 
Terpenoids + + 
Alkaloids + -- 
Cardiac glycosides + + 
Table 6.4.1: Phytochemical screening of P.violacea (A) and X.zambesiaca (B) 
extracts. + means present and – means absent. 
 




Figure 6.2: Gallic acid calibration curve for the estimation of P.violacea and 






P.violacea (1 mg/ml) 0.114 0.152 ± 0.0269 
X.zambesiaca (1 mg/ml) 0.063 0.0895 ± 0.006 





Phytochemicals are inexpensive, effective, readily applicable and accessible 
bioactive compounds (Okwu, 1999). The present study carried out on P.violacea and 
X.zambesiaca plant extracts revealed the presence of medicinally active 
constituents. The phytochemically active compounds of P.violacea and 
X.zambesiaca were qualitatively analyzed in a mixture of twigs, leaves and flowers of 
each plant. The phytochemical screening results in Table 6.4.1 revealed the 
presence of tannins, flavonoids, steroids, terpenoids, alkaloids and cardiac 
glycosides from P.violacea (leaves, flowers and twigs) extract, while X.zambesiaca 
(leaves, flowers and twigs) extract showed the presence of flavonoids, saponins, 
terpenoids and glycosides.  
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The medicinal value of plants lies in some chemical substances such as alkaloids, 
tannins, flavonoids and other phenolic compounds, which have a definite 
physiological action on the human body (Hill, 1952). Different phytochemicals have 
been found to possess a wide range of activities, which may help in protection 
against chronic diseases. For example, alkaloids protect against chronic diseases, 
saponins protect against hypercholesterolemia and antibiotic properties, steroids and 
triterpenoids have analgesic properties and steroids and saponins are responsible 
for central nervous system activities. Phytochemical screening of P.violacea and 
X.zambesiaca plant extracts was investigated to study the presence of alkaloids, 
flavonoids, steroids, saponins, tannins, terpenoids and cardiac glycosides. 
 
The beneficial health effects of plants are attributed to flavonoids, a class of 
secondary metabolites that protect the plant against ultraviolet light and even 
herbivores (Harbone and Williams, 1992). The protective effects of flavonoids are 
due to their capacity to transfer electrons to free radicals. Alkaloids and their 
synthetic derivatives are used as basic medicinal agents for their antispasmodic and 
bactericidal effects (Stray, 1998; Okwu, 2004). Alkaloids in X.zambesiaca may be 
responsible for its antibacterial effect (Masoko, 2013). Tannins in P.violacea have 
astringent properties and hasten the healing of wounds (snakebite) and inflamed 
mucous membranes (due to tuberculosis/colds) (Mnxati, 2009). X.zambesiaca have 
been proven to have isoflavones (Harper et al., 1976). The isoflavones bind to 
estrogen receptors in the body, thereby blocking the cancer-promoting effects of 
estrogen (Reddy et al., 2003). This compound might be beneficial for the prevention 
of ovarian cancer, but this can only be verified by anticancer screening of this extract 
on the ovarian cell line. 
 
Phenolic compounds are commonly found in the plant kingdom and have been 
reported to have multiple biological effects, including antioxidant activity (Kähkönen 
et al., 1999). Polyphenols are the most abundant antioxidants in our diet. Foods and 
beverages rich in polyphenols may have great potential with respect to prevention of 
diseases. Estimated total phenolic content in this study was measured using the 
Folin-Ciocalteau assay and a phenolic acid (such as gallic acid) to set up a 
calibration curve (Figure 6.2). Total phenolic content was estimated using the gallic 
standard curve and expressed as GAE in mg/g extract (Singleton and Rossi, 1965). 
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Table 6.4.2 displays the estimated total phenol content values of P.violacea and 
X.zambesiaca extracts, which were analyzed at 1 mg/ml against gallic acid.  
 
Polyphenolic compounds are effective in the prevention of oxidative stress related 
diseases. Both plant extracts showed the presence of flavonoids. Flavonoids are a 
group of polyphenolic compounds with diverse characteristics and chemical 
structures. The therapeutic potential of these flavonoids has been determined and 
they are known to have a number of pharmacological and biochemical properties, 
namely antibacterial, antiviral, anti-allergic, vasodilatory and anti-inflammatory ones, 
exhibiting activity against the enzymes cyclo-oxygenase and lipoxygenase. 
(Middleton et al., 2000). P.violacea extracts showed more polyphenols than 
X.zambesiaca. The GAEs of the estimated phenolic concentrations ranged from 
0.152 ± 0.0269 to 0.0895 ± 0.006 mg/GAE. The total phenolic content of 
X.zambesiaca extracts showed a correlation with the antioxidant activity determined 
in Chapter 5. However, there was no correlation on total phenol content values of 
P.violacea and active biological compounds it comprises. P.violacea showed the 
presence of flavonoids and alkaloids, which are known for their effects as antioxidant 
and anticancer agents, but at the same time they had no antioxidant and anticancer 
properties, as discussed in Chapter 2 and Chapter 5. Intensive research is still 
needed to comprehend the pharmacological effects and the identification of 





The plants screened for phytochemical constituents seemed to have the potential to 
act as a source of useful drugs and also to improve the health status of the 
consumers as a result of the presence of various compounds that are vital for good 
health. 
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Nature has been a good supply of various medicinal agents for thousands of years 
and more than 50% of modern drugs have been isolated from natural sources such 
as plants. Both P.violacea and X.zambesiaca species have been used in traditional 
remedies by South Africans for years. P.violacea is traditionally used to treat 
inflammation-related disorders and diarrhea, while X.zambesiaca is used to treat 
diabetes mellitus. It was previously demonstrated that the latter has anti-tuberculosis 
activity and antihyperglycemic activity in diabetic mice. The aim of this study was to 
determine the chemical composition of methanol crude extracts (mixture of twigs, 
leaves and flowers) of P.violacea and X.zambesiaca. Liquid chromatography-mass 
spectrometry (LC-MS) analysis of these plant extracts showed the presence of nine 
compounds: 4-Acetoxy-3,5-dimethoxybenzoic acid, 2″-O- β –D-Apriofuranosyl, 6″-O-
α-L-rhamnopyranosyl, Quercetin-3-O-[α-L- rhamnopyranosyl(1→6)]-β -D-
galactofuranoside, 3-O- β –D-Galactopyranosyloxy-3' .4' .5.7-tetrahydroxyflavone, 
Quercetin 3-galactoside, 7-O-[α-L-Rhamnopyranosyl-(1→6)- β-D-glucopyranoside] 
or 6,8-Bis(C-β-glucosyl)-apigenin, 3-O-[α-L-Rhamnopyranosyl-(1→2)-β-D-
glucopyranoside], 20-O-α-L-rhamnopyranoside and two unknown compounds  from 
P.violacea, and seven compounds, Apigenun-6-C-α-L-arabinopyranosyl-8-C- β -L-
arabinopyranoside, Metaplexigenin-3-O- β-D-oleandropyranosyl-(1→4)- β-D-
digitoxopyranosyl -(1→4)- β-D-digitoxopyranoside, Arvenin I, 3-O- β-D-
Glucuronopyranoside: (Cloversaponin II), Apigenin-4’-O- β –D-xylofuranodyl(-(1→4)-
O- β-D-glucopyranoside and 6-Me ether, 7-O- β –D-galactopyranoside: 
(Chamaejasmoside) from X.zambesiaca. Identified compounds correlate with the 
reported total phenolic content results shown in Chapter 6 of this study, as it was 
demonstrated that P.violacea has more phenols that X.zambesiaca. 
 





Plants have an almost limitless ability to synthesize chemical substances, mainly 
secondary metabolites, of which numerous compounds have been isolated (Rafael, 
2008). Chemical analysis of P.violacea showed the presence of tannins, flavonoids, 
steroids, terpenoids, alkaloids and cardiac glycosides and X.zambesiaca showed the 
presence of flavonoids, saponins, terpenoids and glycosides, reported in Chapter 6. 
The existence of such chemical compounds was expected, as their derivatives are 
found in most plants. Alkaloids, flavonoids, terpenoids, tannins, phenolics and many 
others are very important for both humans and plants (Rafael, 2008). They act as 
cell wall support materials (Wallace, 1994) and as colorful attractants for birds and 
insects, helping seed dispersal and pollination (Harborne, 1994). Flavonoids and 
phenolic acids have also been reported as having antioxidative (Robards et al., 
1999) and anticarcinogenic effects (Stavric, 1994). 
It is estimated that about 61% of the 877 small molecule new chemical entities 
introduced as drugs worldwide in the past 30 years were developed from natural 
products (Satyajit and Lutfun 2007). It was also estimated that about 74% of 
anticancer drug candidates are natural products or structural analogues of natural 
products. Approximately 60% of all drugs in clinical trials for a multiplicity of cancers 
are of natural origin. In the past, the identification of compounds was labor-intensive, 
time-consuming and required too much sample. However, modern drug discovery 
approaches apply full automation and robotics where hundreds of molecules can be 
screened, using several assays within a short time and very small amounts of 
compounds. A number of techniques are used for the identification and analysis of 
plants chemical constituents such as liquid chromatography–mass spectrometry 
detector (LC-MS) detector and liquid chromatography–nuclear magnetic resonance 
spectroscopy. Therefore, the aim of this study was to determine the chemical 
composition of methanol crude extract (mixture of twigs, leaves and flowers) of 
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7.2 LITERATURE REVIEW 
 
LC-MS is a chromatographic technique used to separate a mixture of compounds 
with the purpose of quantifying and identifying the specific components of the 
mixture. High performance liquid chromatography (HPLC) was revolutionized in 2004 
by Waters into a new sophisticated, fast, high-resolution separation instrument with 
sensitivity of analysis called ultra-performance liquid chromatography (UPLC)  
(Grumbach, 2011). This UPLC fractionates and isolates chemical compounds in 
short periods of time with little solvent consumption and minute quantities of sample 
(Stephen and Tchelitcheff, 2006). Kang (2011) determined the robustness, fast 
speed and good resolution of UPLC and its ability to consume less solvent than 
HPLC. HPLC uses more solvent and solution to be tested, is time-consuming and 
generates high back-pressure that influences the analytical column. The original 
HPLC method takes about 35 minutes to two hours per analysis, while UPLC takes 
about five minutes (Grumbach, 2011). HPLC generates high column back-pressure 
when smaller size particles are used because of the short column used but this does 
not cause loss of efficiency. 
The principle of UPLC is governed by the van Deemter equation: H= A + B/v + Cv 
(Grumbach, 2011). Where A is a constant velocity representing the Eddy dispersion, 
B (axial dispersion) is the diffusion of molecules, C is the kinetic resistance (high 
temperature, small particles and core-shell particle), and v is the flow rate. This 
equation describes the relationship between flow rate and high equivalent of 
theoretical plate (HETP)/column efficiency, which is dependent on the diameter of 
particles packed into the analytical column (Swartz, 2005). Column packing particle 
size is inversely proportional to efficiency and resolution. As particle size decreases 
below 2,5 µm, efficiency increases; this leads to high speed and peak capacity 
(Swartz and Murphy, 2004) resulting in a rapid increase in back-pressure. UPLC is 
designed to use low volume injections with minimal carryover to achieve high 
sensitivity, accuracy and precision (Lucie et al., 2006). UPLC provides resolution, 
speed and sensitivity with no compromises. This instrument allows short analysis 
time, uses very small particle packed analytical columns and performs under very 
high pressures without influencing the analytical column or other components of the 
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chromatographic system (Swartz, 2005). High back-pressure improves 
chromatographic resolution. UPLC increases productivity because it is fast. 
 
There are two classes of compounds from plants, namely primary and secondary 
metabolites. Primary metabolites are required for the sustenance of the plant, while 
secondary metabolites are not a necessity for the plant‘s survival (Harborne and 
Baxter, 1999). The latter are mostly compounds that are active for treatment and 
prevention of diseases in humans and animals and are thus termed bioactive 
compounds. Bioactive compounds are generally unique to individual plant species 
and are thus species-specific, but some may be found in several or many plant 
species of a genus, in several related genera, or even families (Kinghorn et al., 
2003). The crucial factor for definitive accomplishment of isolating bioactive plant 
constituents is the selection of the ―right‖ plant and the relevant part of the plant, 
which contains the active compounds. As distillate, certain secondary metabolites in 
specific organs and variation in bioactivity are often encountered in different parts of 
the same plant (O‘Neill and Lewis, 1993).  
 
Previous investigations of X.zambesiaca revealed the presence of 7,8-dioxy-
isoflavonoids, 2-benzylbenzo[b]furan-3(2H)-ones (Bezuidenhout et al., 1987), along 
with the isolation of novel isoflavones, 7,8,3‘-trihydroxy-4‘-methoxyisoflavone and 
α,3,4,4‘-tetrahydroxy-2‘-methoxydihydrochalone (Bezuidenhout et al., 1988). 
However, these were isolated from the heartwood of the plant and it is known that 
different parts of the plant may contain dissimilar compounds. X.zambesiaca leaf 
extract was demonstrated to have five compounds, namely fagomine, 3-epi-
fagomine, 3,4-di-epi-fagomine, 3-O-β-d-glucopyranosylfagomine and 4-O-β-d-
glucopyranosylfagomine (Kato et al., 1997). The two compounds mentioned last 
were identified as new natural products. Fagomine is a good inhibitor of isomaltase 
and certain α- and β-galactosidases, whereas 3-epi-fagomine is a more potent 
inhibitor of isomaltase and β-galactosidases than fagomine, but does not inhibit α-
galactosidase. Compound 3,4-di-epi-fagomine exhibited no significant inhibition 
against the glycosidases used (Kato et al., 1997). X.zambesiaca was also identified 
as having diarylpropanes such as diarylalkanes and/or diarylalkanols, which have 
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the capability of inhibiting binuclear enzyme function, particularly tyrosinase, which 
prevents melanin overproduction. When one considers that a single plant may 
contain up to thousands of phytoconstituents, the possibilities of making new 
discoveries become self-evident. Our phytochemical investigation of X.zambesiaca 
and P.violacea (mixture of leaves, twigs and flowers) has resulted in the identification 
of other compounds of which the presence has not been recorded before from these 




7.3.1 Plant material 
The plant materials P.violacea and X.zambesiaca were authenticated by scientists at 
the National Botanical Gardens in Bloemfontein, South Africa (MAS002). The 
collected material was dried at room temperature, pulverized by mechanical mills 
and weighed. It was then stored in a cool place until analysis. 
7.3.2 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours with occasional stirring.  The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol extract was concentrated using a rotator evaporator.  
7.3.3 Identification of active compounds with LC-MS 
LC–MS/MS analysis for the identification of active compounds from P.violacea and 
X.zambesiaca methanol crude extracts was carried out using the Waters Synapt G2 
instrument. This is an Agilent 1100 LC system consisting of degasser, binary pump, 
auto sampler and column heater. The column outlet was coupled to an Agilent MSD 
Ion Trap XCT mass spectrometer equipped with an ESI ion source. Data acquisition 
and mass spectrometric evaluation were carried out on a personal computer with 
Acquity binary solvent manager instrument system. For the chromatographic 
separation, Waters UPLC on a Waters BEH C18, 2.1x100 mm column was used. 
The column was held at 95% solvent A (0.1% formic acid in water) and 5% solvent B 
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(0.1% formic acid in acetonitrile) for 1 min, followed by an 11 min step gradient from 
5% B to 100% B, then it was kept for 4 min with 100% B; finally, the elution was 
achieved with a linear gradient from 100% B to 5% B for 2 min. The flow rate was 0.4 
ml/min and the injection volume was 0.01 ml. The following parameters were used 
throughout all MS experiments: for electrospray ionization with negative ion polarity 
the capillary voltage was set to 3 kV, the drying temperature to 3500C and cone 
voltage of 15 V, the maximum nebulizer pressure to 15000 psi and the seal wash 
was 5 min. The total run time was 15 minutes, the scan speed was 26 000 m/z/s 
(ultra-scan mode) and the lock mass was Leucine enkaphelin. The phenolics were 
identified using a combination of HPLC with diode array detection and liquid 
chromatography with atmospheric pressure chemical ionization mass spectrometry 
(ESI-LC/MS/MS) on the basis of their ultraviolet  spectra, mass spectra and by 




Figure 7.1: LC/MS chromatograms of P.violacea extract (ESI negative). Nine phenolic 















Figure 7.2: (A) mass spectrum (peak at 2.2 min) of identified compound numbered 1 from 










Figure 7.2: LC/MS chromatograms of X.zambesiaca (ESI negative). Seven phenolic 









Figure 7.2: (A) mass spectrum (peak at 2.2 min) of identified compound numbered 1 from 
Xanthorcercis zambesiaca. (B) Elemental composition predictions of identified compound 







4 2 533.1 825.4 
(A) 
(B) 
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Table 7.1: Identification of phenolic compounds in P.violacea methanol extract using 
their mass unit and retention times. 
Peak (m/z) Rt (min) Tentative ID References 
1 239.05 2.24 4-Acetoxy-3,5-dimethoxybenzoic acid  (All chemical 
compounds, 
2012) 
2 741.18 2.71 2″-O- β –D-Apriofuranosyl, 6″-O-α-L-
rhamnopyranosyl 
(Yannai, 2004) 
3 609.14 2.94 Quercetin-3-O-[α-L- 
rhamnopyranosyl(1→6)]-β -D-
galactofuranoside 
(Zhou et al., 
2011) 




5 593.14 3.32 7-O-[α-L-Rhamnopyranosyl-(1→6)- β-
D-glucopyranoside] 
or 6,8-Bis(C-β-glucosyl)-apigenin 
(Zhou et al., 
2011) 




7 895.50 6.87 Unknown * 
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9 293.21 8.04 Unknown * 
Identification was aided by comparison with previous literature reports. 
(m/z) = Molecular mass, Rt = retention time, * = no literature 
 
Table 7.2: Identification of phenolic compounds in X.zambesiaca methanol extract 
using their mass unit and retention times. 
Peak (m/z) Rt (min) Tentative ID References 
1 563.14 2.75 Apigenin-4’-O- β –D-xylofuranodyl(-
(1→4)-O- β-D-glucopyranoside and 
6-Me ether 
(Zhou et al., 2011) 
2 533.1 2.29 Apigenun-6-C-α-L-arabinopyranosyl-
8-C- β -L-arabinopyranoside,  
(Zhou et al., 2011) 
3 513.1 3.69 7-O- β –D-galactopyranoside: 
(Chamaejasmoside) 
(Yannai, 2004) 





5 719.3 5.80 23,24-Dihydro, 25-Ac, 2-O-b-D-
glucopyranoside: 
(Yannai, 2004) 







7 661.35 6.84 3-O- β-D-Glucuronopyranoside: 
(Cloversaponin II) 
(Yannai, 2004) 
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Identification was aided by comparison with previous literature reports 




In this study, LCMS techniques have been employed to investigate the phenolic 
content of P.violacea and X.zambesiaca methanol plant extracts. This was aimed at 
identifying only compounds present in these plant extracts, but not to isolate and re-
analyze the activity of the isolated active compounds. Fragmentation of the 
compounds by the mass spectrum was performed to obtain the molecular chemical 
formula of the compounds that formed significant peaks. The relative retention times 
and mass spectra of the extract components were compared with those of authentic 
samples and with mass spectra from a data library. As shown in Figure 7.1, LC-MS 
analysis of the P.violacea methanol extract resulted in the identification of nine 
compounds, with more than 90% similarity with the standard mass spectra in the 
library. The LC-MS analysis of X.zambesiaca extract shown in Fig 7.2 resulted in the 
identification of seven compounds, also with more than 90% similarity with the 
standard mass spectra in the library. 
In short, for P.violacea LC-MS analysis, the first five components with the greatest 
peak area to be eluted were at 2.24 min till 3.32 min (peak 1 to peak 5), which was in 
the more hydrophilic region (short retention time). The other four main components 
eluted at 6.47 min (peak 6), 7.81 min (peak 7), 6.87 min (peak 8) and 8.04 min (peak 
9) in the more hydrophobic region (longer retention time). Then, for X.zambesiaca 
LC-MS analysis, the first three components were eluted in the more hydrophilic 
region, with the greatest peak area at 2.75 min till 3.69 (peak 1 to peak 3) and the 
other four main components eluted in the more hydrophobic region at 4.93 min till 
6.84 min (peak 4 to peak 7). The deprotonated molecule mass (m/z) measured by 
the MS in ESI negative mode was used to determine the molecular formula of the 
compounds extracted. The tentative names of these identified compounds were 
determined using the molecular formula and the molecule mass, using the literature 
(Yannai, 2004).  
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The following compounds were identified: 4-Acetoxy-3,5-dimethoxybenzoic acid, 2″-
O- β –D-Apriofuranosyl, 6″-O-α-L-rhamnopyranosyl, Quercetin-3-O-[α-L- 
rhamnopyranosyl(1→6)]-β –D-galactofuranoside, 3-O- β –D-Galactopyranosyloxy-3’ 
.4’ .5.7-tetrahydroxyflavone. Quercetin 3-galactoside, 7-O-[α-L-Rhamnopyranosyl-
(1→6)- β-D-glucopyranoside] or 6,8-Bis(C-β-glucosyl)-apigenin, 3-O-[α-L-
Rhamnopyranosyl-(1→2)-β-D-glucopyranoside], 20-O-α-L-rhamnopyranoside and 2 
unknown compounds  from P.violacea, and 7 compounds: Apigenun-6-C-α-L-
arabinopyranosyl-8-C- β –L-arabinopyranoside, Metaplexigenin-3-O- β-D-
oleandropyranosyl-(1→4)- β-D-digitoxopyranosyl –(1→4)- β-D-digitoxopyranoside, 
Arvenin I, 3-O- β-D-Glucuronopyranoside: (Cloversaponin II), Apigenin-4’-O- β –D-
xylofuranodyl(-(1→4)-O- β-D-glucopyranoside and 6-Me ether, 7-O- β –D-
galactopyranoside: (Chamaejasmoside) from X.zambesiaca. There was no literature 
on the identification of these compounds from species belonging to the Fabacea 
family. Therefore, this is the first report of the presence of these compounds from 
methanol extract (leaf, twig and flower mixture) from P.violacea and X.zambesiaca 
belonging to the Fabacea family. 
X.zambesiaca was found to contain compounds with a molecule structure named 
‗pyranoside‘ and ‗pyranosyl‘ in abundance. Pyranoside has been reported to possess 
neuroprotective properties (Chen et al., 2014; Yu et al., 2014) and pyranosyl has 
been reported as an iron-chelating agent. Furthermore, control of iron in the body by 
chelating drugs may have a significant beneficial effect on tissue damage caused by 
free radicals (Lauffer, 1992). Therefore, the presence of this molecule in 
X.zambesiaca may support its activity against free radicals, as demonstrated in 
Chapter 5 of this study.  
 
P.violacea has also been found to contain pyranoside pyranosyl and two unknown 
compounds; in addition to that, flavonoids were present in abundance. Flavonoids 
are classified into various classes (Singh et al., 2014), such as flavonols (quercetin), 
flavones (apigenin), flavanones (hesperetin, naringenin), flavonoid glycosides 
(astragalin, rutin), flavonolignans (silibinin), flavans (catechin, epicatechin) to name a 
few. Flavones are reported as possible antioxidant, anti-proliferative, anti-tumor, anti-
microbial, estrogenic, acetyl cholinesterase, anti-inflammatory agents and are also 
used to treat cancer, cardiovascular disease and neurodegenerative disorders 
© Central University of Technology, Free State
103 
 
(Middleton and Chithan, 1993; Cushnie and Lamb, 2005). Despite the presence of 
abundant flavones in this plant extract, tests for its anticancer, antioxidant and 
antimicrobial activity yielded negative results. Therefore there was no correlation with 
the identified active compounds and pharmacological activities of this plant and this 
was not expected. This might be due to the concentration of these compounds; they 
are present, but not in large quantities. To elucidate this, each part of this plant must 
be analyzed separately and a quantitative analysis to determine the amount of active 




Nature has been a good supply of various medicinal agents for thousands of years 
and more that 50% of modern drugs have been isolated from plants. LC-MS analysis 
of P.violacea and X.zambesiaca demonstrated the presence of respectively nine and 
seven compounds from these methanol plant extracts. These identified compounds 
have pharmacological properties that may be beneficial to human beings as 
chemopreventative agents. However, this can only occur after the isolation of these 
active compounds. Two unknown compounds identified from P.violacea need further 
study in order to identify them, as they are nowhere to be found in the current 
literature. 
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The science of radiation protection is a fundamental result of peaceful and fully 
equipped applications of ionizing radiation. Several chemical agents/synthetic 
radioprotectors have been tried against the hazardous effects of ionizing radiation in 
experimental studies with success and satisfactory outcomes. In the previous 
investigations X.zambesiaca was demonstrated as having antioxidant activity. The 
aim of this study was to confirm the free radical scavenging features of 
X.zambesiaca methanol extract. Human prostate cancer cells (DU145) were 
irradiated to 2 Gy in the presence of the extract at a concentration of 0.1 mg/ml and 
the cell surviving fraction (SF2 - with X.zambesiaca) was determined using the 
colony-forming assay. Based on clonogenic cell survival, X.zambesiaca showed 
significant radiation protection with a radioprotective factor value of 1.53, indicating 
that X.zambesiaca can lead to over 50% reduction in cell death. This confirms the 






The most injurious effects on the viability of cells and human health are oxidative 
changes in nucleic acids, which cause mutagenic processes and cancer (Ferrari and 
Torres, 2003). According to the WHO (2012), cancer is the second leading cause of 
death worldwide. Therefore, prevention of cancer development and its treatment 
remains a serious challenge for scientists worldwide. One of the most popular and 
important tools used to cure cancer in current radiation therapy is X-radiation 
(Ertekin et al., 2004). Although radiation is capable of damaging many cellular 
components, the main target is nuclear DNA. Radiation energy results in both direct 
and indirect effects, e.g. the production of free radicals, such as superoxide anion in 
human lymphocytes (Belloni et al., 2008). Previous studies have shown that known 
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antioxidants, such vitamins C and E and b-carotene, were protective against genetic 
damage induced by exposure to gamma radiation (Konopacka et al., 1998). 
 
Plant polyphenols are important components of human diet and a number of them 
are considered to possess chemopreventive and therapeutic properties against 
cancer (Sebastià et al., 2014). They are recognized as naturally occurring 
antioxidants but also as pro-oxidant, pro-apoptotic or chromosomal aberration 
inducers (Sweeney, 1979; Weiss and Landauer, 2003). Polyphenolic compounds 
possess a wide range of pharmacological properties and their mechanisms have 
been the subject of considerable interest. The science of radiation protection is a 
fundamental result of peaceful and fully equipped applications of ionizing radiation. 
Several chemical agents/synthetic radioprotectors have been tried with success and 
satisfactory outcomes against the hazardous effects of ionizing radiation in 
experimental studies (Pallavi et al., 2012). However, the practical applicability of the 
majority of these synthetic compounds remains limited, owing to their high toxicity at 
their optimum protective doses (Sweeney, 1979).  
 
Natural medicinal drugs offer an alternative to synthetic compounds and are 
considered either nontoxic or less toxic than their synthetic counterparts. A large 
number of plants containing antioxidant phytochemicals are reported to be 
radioprotective in various model systems (Pallavi et al., 2012). Most plants with 
antioxidant properties have shown anticarcinogenic activities in several in vitro and in 
vivo assays (Signorelli and Ghidoni, 2005; Shishodia et al., 2007; Epstein et al., 
2010; Koide et al., 2011). They have also shown the capacity to modulate radiation-
induced damage by means of various biological endpoints, by radiosensitizing tumor 
cells while radioprotecting non-cancerous cells (Sebastià et al., 2014). This suggests 
that, besides the anticarcinogenic effect, another possible application of the 
antioxidant capacity of polyphenols from plants could be based on their 
radioprotective activity. P.violacea showed less potential to scavenge free radicals 
(see Chapter 5), thus it was excluded in the determination of radioprotective effect. 
The present study aimed at evaluating the radioprotective effect of methanolic 
extract of X.zambesiaca on radiation-induced human prostate cancer cell lines at a 
dose of 2 Gy. 
© Central University of Technology, Free State
109 
 
8.2 LITERATURE REVIEW 
 
8.2.1 Effects of ionizing radiation on the immune system of organisms 
Radiation protection, also known as radiological protection, is the science and 
practise of protecting people and the environment from the harmful effects of ionizing 
radiation. It is commonly applied to cancerous tumors because of its ability to control 
cell growth. Ionizing radiation works by damaging the DNA of cancerous tissue, 
leading to cellular death. To spare normal tissues (such as skin or organs, which 
radiation must pass through to treat the tumor), shaped radiation beams are aimed 
from several angles of exposure to intersect at the tumor, providing a much larger 
absorbed dose at the target area than in the surrounding, healthy tissue. The amount 
of radiation used in photon radiation therapy is measured in gray (Gy), and varies 
depending on the type and stage of cancer being treated. A significant radiation 
dose-dependent effect was shown to be from 1 to 7.5 Gy (Manda et al., 2014) and in 
this study a moderate dose of 2 Gy gamma-radiation was used. 
Any radiation whose interaction with the environment leads to the formation of the 
electric charges of opposite signs (positive and negative) is considered ionizing 
radiation. This includes various types of micro-particles and physical fields capable 
of ionizing any substance. In turn, the ultraviolet radiation and visible light range are 
not ionizing but in some cases they may be the same (Russian, 2009). The effects of 
any doses of ionizing radiation on any living organism result in changes in 
morphology and functional activity, both at the cellular and system levels, causing an 
increase or suppression of immune reactivity whose final manifestation is 
immunodeficiency. The consequence of immunodeficiency is auto-sensitization of 
organisms, the development of opportunistic infections caused by pathogenic micro-
flora, oncological diseases and other complications (Kusunoki and Hayashi, 2008). A 
safe compound that would prevent the ablation of immune system function and other 
radiation-induced oxidative tissue damage would provide an effective medical 
countermeasure against nuclear or radiological attack. 
© Central University of Technology, Free State
110 
 
8.2.2 Biological damage by radiation 
Radiation therapy leads to the DNA damage of cancerous cells. DNA damage can 
be caused by one of two types of energy, photon or charged particle. The damage is 
either direct or indirect ionization of the atoms that make up the DNA chain. Indirect 
ionization occurs as a result of the ionization of water, forming free radicals, notably 
hydroxyl radicals, which then damage the DNA (Butler et al., 1984). In photon 
therapy, most of the radiation effect is through free radicals (Hadi et al., 2007). Cells 
have mechanisms for repairing single-strand DNA damage and double-stranded 
DNA damage. However, double-stranded DNA breaks are much more difficult to 
repair and can lead to dramatic chromosomal abnormalities and genetic deletions. 
Targeting double-stranded breaks upsurges the probability that cells will undergo cell 
death.  
Cancer cells are generally less differentiated and more stem cell-like; they reproduce 
more than most healthy differentiated cells and have a diminished ability to repair 
sub-lethal damage. Single-strand DNA damage is then passed on through cell 
division; damage to the cancer cells‘ DNA accumulates, causing them to die or 
reproduce more slowly. Radiation is understood to effect cancer treatment by 
destroying the proliferative capacity of tumor cells and is effective in controlling local 
disease. Recent evidence suggests that the intrinsic radiosensitivities of cells derived 
from various cancers correlate with the amount of radiation dose required in 
controlling those cancers (Perron et al., 2011). Several physical, chemical, biological 
and physiological factors that influence cellular radiation response have been well 
characterized and are important in understanding the radio-responsiveness of 
individual tumors. Recently, research into radioprotection from plants has escalated 
in the hope of developing improved cancer treatment that will eventually result in 
improved local control and additional cures of this disease. 
8.2.3 Mechanisms of radiation protection 
A variety of radioprotective mechanisms have been proposed to elucidate the 
prophylactic and therapeutic effects of a large number of agents (Maisin, 1998; Nair 
et al., 2001; Weiss and Landauer, 2003). Naturally occurring antioxidants are only 
one class of radioprotectors. Although a large number of potential radioprotectors, 
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especially those containing sulfhydryl groups, can be considered antioxidants, as 
they are clear protectors that work mainly through receptor-mediated mechanisms, 
e.g. bioactive lipids, cytokines and growth or through receptor-mediation, but 
produce similar results even though the pathways are different. Sulfhydryl 
compounds may protect cellular DNA by a combination of mechanisms, including 
free radical scavenging, hydrogen donation and modulation of repair processes 
(Murray, 1998), whereas a cytokine may induce cellular antioxidant activity, such as 
superoxide dismutase and metallothionein, via receptor-mediated mechanisms 
(Neta, 1997). 
The radioprotectors can elicit their action by various mechanisms, such as: 1) by 
suppressing the formation of reactive species, 2) detoxification of radiation-induced 
species, 3) target stabilization and 4) enhancing the repair and recovery processes 
(Nair et al., 2001). Pharmacological agents were found to be radioprotective by 
interfering with the delivery of oxygen into irradiated tissues. The chemical or 
biochemical consumption of oxygen can bring about hypoxia in cells and tissues. 
This may be one of the mechanisms by which sulphydryl compounds (RSH), which 
can undergo an oxidation reaction with molecular oxygen, manifest radioprotection 
(Halliwell and Gutteridge, 1984). Several free-radical scavengers are known to 
interact with aqueous free radicals and to prevent the radiation-induced lethality of 
cells. The radioprotectors may also react with water radicals or radicals of bio-
molecules (X•) by donating hydrogen atoms to repair the radical species:  
   2 X• + 2 RSH ⇒ 2 XH + RSSR 
 2 RSH + 2OH ⇒ RSSR + 2H2O 
Radioprotectors can also interact with cellular targets, like DNA, by forming mixed 
disulfides and prevent radiation damage by stabilizing the target. Several amino thiol 
radioprotectors, such as cysteamine, guanidoethyldisulfide and glutathione disulfide, 
bind to DNA and their DNA binding parallels their radioprotective potency (Nair et al., 
2003). The radioprotective activity of a number of thiol compounds (RSH, R‘SH etc.) 
has been correlated with the ratio and extent of mixed disulfide (RSSR‘) formation 
(Nair et al., 2001). The regeneration of native proteins can be achieved by a thiol 
disulfide exchange with glutathione, possibly catalyzed by thiol transferase, and 
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subsequent action of glutathione redox system coupled with glutathione reductase 
and NADPH. However, the mixed disulfide hypothesis is limited to the protection of 
enzymes and proteins and fails to explain the radioprotection of nucleic acids, 
because the SH group is restricted to proteins only. 
8.2.4 Radioprotection from plants 
Phenolic compounds can reduce reactive oxygen species (ROS) levels in the cellular 
environment and play an important role in modulating oxidative stress (Lee & Park, 
2003). These compounds are known as anti-carcinogenic food components owing to 
their antioxidant activity (Page et al., 2011). The relationship between antioxidant 
structures and their activity has been investigated in many studies, and the structural 
arrangements exerting the greatest antioxidant activity of the compound have been 
identified. Among these structures, the most widely investigated group of compounds 
are flavonoids (Burda and Oleszek, 2001; Rice-Evans et al., 1996). Most studies 
have been performed using aglycones and flavonoid glycosides, which occur 
naturally in plant tissues (Wolfe and Liu, 2008; Kweon et al., 2001). Plant species 
have been examined according to the content of bioactive phenolic compounds in 
relation to the antioxidant activity (Kweon et al., 2001; Ferreres et al., 2008) and 
correlation was observed. Results from these studies further confirmed the potential 
of these compounds as antioxidant agents. 
 
Naturally occurring polyphenols comprise a wide variety of compounds divided into 
several classes that occur in fruit and vegetables, wine and tea, chocolate and other 
cocoa products (Manach et al., 2004). The beneficial effects of phytophenols are 
mainly attributed to their antioxidant properties, since they can act as chain breakers 
or radical scavengers, depending on their chemical structures (Rice-Evans, 2001). 
Gallic acid is a polyhydroxy-phenolic compound (Figure 8.1) and is nontoxic to 
mammals at pharmacological doses (Okuda et al., 1993; Hatano, 1995; Takana, 
1999). Gallic acid is known to have anti-inflammatory, antioxidant, free radical 
scavenging, and radioprotective activity (Kroes et al., 1992; Gandhi and Nair, 2005; 
Lo Scalzo, 2010). It is employed as an antioxidant in food, in cosmetics and in the 
pharmaceutical industry (Kähkönen et al., 1999)  
 




Figure 8.1: Gallic acid (GA) [3,4,5-trihydroxybenzoic acid] (Hatano, 1995). 
 
On the other hand, some polyphenols from plants were demonstrated as 
radiosensitizers by means of their pro-oxidant activities or as inducers of 
chromosomal aberrations leading to cell death or apoptosis (Sandeep and Nair, 
2011; Ramachandran and Nair, 2011; Manach et al., 2004; Rice-Evans, 2001). 
Since ionizing radiation and chromosomal aberrations have been associated with 
cancer, such chemically induced chromosomal radiosensitization may escalate the 
risk of carcinogenesis (Hatano, 1995). Cell cycle interference related to repair 
processes of radiation-induced damage and the activation of checkpoints is, 
therefore, avoided. The effect of these polyphenols on the induction and repair of 
radiation-induced chromosomal aberrations in cycling cells has also been 
investigated in other studies.  
Protection of biological systems from ionizing radiation is of supreme significance in 
planned as well as unplanned, accidental exposure to radiation (Arora et al., 2005; 
Jagetia 2007), and the development of new and effective agents to combat radiation 
damage using nontoxic radioprotectors is of considerable interest in health care, 
particularly in radiodiagnostics and therapy. Many synthetic as well as natural 
compounds have been investigated in the recent past for their efficacy to protect 
biological systems against the harmful effects of radiation. These include sulfhydryl 
compounds, antioxidants, plant extracts, immunomodulators and other agents 
(Maisin, 1998; Nair et al., 2001). However, the inherent toxicity and side effects of 
the synthetic agents at the effective radioprotective concentration warrants a further 
search for safer and more effective radioprotectors. Extracts of various plants with 
free radical mediated conditions in humans can be beneficial, as they contain 
compounds having antioxidant activity, which can prevent damage induced by ROS 
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and reactive nitrogen species (Arora et al., 2006). Therefore, in the present study, 




8.3.1 Plant material 
The plant material X.zambesiaca was authenticated by scientists at the National 
Botanical Gardens in Bloemfontein, South Africa. The collected material was dried at 
room temperature, pulverized by mechanical mills and weighed. It was then stored in 
a cool place until analysis. 
8.3.2 Extraction method 
The extraction was done using the maceration. Plant material (10 g of the dried 
twigs, leaves and flowers of each plant) was weighed, pulverized and soaked in 
methanol for 72 hours with occasional stirring.  The extracts were filtered and new 
solvent was added again for more extraction until the solvent remained clear. The 
methanol solvent was removed completely using a rotator evaporator. 
8.3.3 Cell culture 
Human prostate cancer cells (DU145) were obtained from Professor P Bouic 
(Synexa Life Sciences, Montague Gardens, South Africa), and grown in Minimum 
Essential Medium (Sigma-Aldrich, Germany) supplemented with 10% heat-
inactivated fetal bovine serum (HyClone, UK), penicillin (100 U/ml) and streptomycin 
(100 µg/ml) (Lonza, Belgium). Cultures in exponential growth were trypsinised to 
give single-cell suspensions, plated in triplicate (400–1500 cells per flask) into 25 
cm2 tissue culture flasks (Greiner Bio-One, Frickenhausen, Germany) and incubated 
for 3 hours to allow the cells to attach.  
8.3.4 Clonogenic assay 
To confirm the free radical scavenging features of extract X.zambesiaca, cell 
cultures were irradiated to 2 Gy in the presence of the extract at a concentration of 
0.1 mg/ml, and were subsequently incubated at 37°C in a humidified atmosphere 
(95% air and 5% CO2) for 10 days to allow for colony formation. The cells were 
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irradiated using a 60Co -irradiation source at a dose rate of 0.827 Gy/min. Colonies 
were fixed in glacial acetic acid:methanol:water (1:1:8, by volume), stained with 
0.01% amido black in fixative, counted, and the cell surviving fraction [SF2 (with 
X.zambesiaca extract)] was determined. Another batch of cell cultures was irradiated 
to 2 Gy in the absence of extract and the corresponding surviving fraction [SF2 (no 
X.zambesiaca extract)] was obtained. To evaluate the radioprotective capacity of the 
extract, an RPF was derived as:   
  RPF = SF2 (with X.zambesiaca)  




Based on the clonogenic assay, the cell surviving fractions for DU145 at 2 Gy with 
and without X.zambesiaca were found to be 0.23 ± 0.13 and 0.15 ± 0.10, 
respectively. The corresponding RPF value emerged as 1.53 ± 0.57, indicating that 
an extract of X.zambesiaca can lead to over 50% reduction in cell death.  This 
confirms the free radical scavenging features of the extract and suggests that it 




Traditionally, radioprotectors are defined as agents that are administered before 
radiation exposure, whereas therapeutic agents are administered after exposure. 
Many naturally occurring antioxidants exhibit a long window of protection, including 
post-irradiation protection against lethality and mutagenesis (Weiss and Landauer, 
2003). In Chapter 5 we illustrated the ability of X.zambesiaca as a free radical 
scavenging agent by determining its antioxidant activity. To prove the radioprotective 
capacity of these antioxidants further, we applied the extract to radiated cancer cells. 
X.zambesiaca plant extract studied in this project showed the capability of offering 
50% protective effect but was less toxic (Chapter 3 of this dissertation) than synthetic 
radioprotectors, such as phosphorothioates. The potential application of this plant as 
a protective agent shows promise - either prophylactic benefits for anticipated 
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exposure in emergency situations or therapeutic benefits after radiation 
accidents/incidents. 
Nuclear and radiological accidents can result in moderate to severe radiation injuries 
and many casualties. The harmful impact of -radiation on biological systems is well 
researched and documented. Aglycones, which are compounds remaining after the 
glycosyl group on a glycoside is replaced by a hydrogen atom, were proven to have 
high radioprotective capacity. The observed radioprotective effect of this compound 
was explained by Konopacka et al. (1998) to result from its antioxidant properties. In 
Chapter 7 of this dissertation, aglycones were found in abundance in X.zambesiaca, 
therefore its radioprotective activity compared relatively well to aglycones‘ 
radioprotective capacity. The results obtained suggested that the free radical 
scavenging activity agents present in this plant extract may be used as compounds 
with promising radioprotective potential. 
 
We have previously reported the free radical scavenging activity of X.zambesiaca. In 
continuation, the present in vitro studies were undertaken to elucidate its precise role 
in the modulation of radiation-induced damage in human prostate cancer cell line. 
DU145 cells were treated with radiation using a 60Co -irradiation source at a dose 
rate of 0.827 Gy/min in order to determine radiation-induced damage. Radiation-
induced DNA clustered lesions and apoptosis are the major likely mechanisms 
implicated in clonogenic cell death. Radiation exposure (2 Gy) triggered a loss of 
clonogenicity in DU145 cells. Cell growth is hindered by alteration of membrane 
permeability, damage to DNA and proteins responsible for cell cycle progression 
(Maddika et al., 2007). Cell count studies and cell surviving fraction values were 
determined, and the RPF value obtained indicated that X.zambesiaca plant extract 
can lead to over 50% reduction in cell death. 
 
These results could be influenced by the increase in cell number and competition 
among growing cells for the available, but limited supply of nutrients and growth 
factors. Such argumentation in cell growth or proliferation rate against radiation 
damage could be the result of several factors, such as inhibition of free radical 
generation, repair of damaged DNA, protection of cell membrane and an increase in 
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the producing ability of cells. Furthermore, the predominant mechanism of radiation 
injury, both in tumors and in normal tissues, is by induction of apoptosis or 
clonogenic cell death by free radical-mediated DNA damage (Karran, 2000). Thus, 
screening potent free radical scavengers as radioprotectors is one of the important 




Based on the clonogenic assay, the radioprotective factor value emerged as 1.53 ± 
0.57, indicating that an extract of X.zambesiaca can lead to over 50% reduction in 
cell death. This confirms the free radical scavenging features of this plant extract and 
suggests that it might be useful as a radioprotector. 
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The objectives of the study were: 
1. To determine the anticancer activity of P.violacea and X.zambesiaca against 
human cell lines. 
2. To determine the mutagenic and anti-mutagenic properties of P.violacea and 
X.zambesiaca extracts. 
3. To determine the antibacterial activity of P.violacea and X.zambesiaca extracts. 
4. To determine the antioxidant activity of P.violacea and X.zambesiaca extracts. 
5. To determine the active phytochemicals of P.violacea and X.zambesiaca 
extracts. 
6. To isolate and identify the bioactive compound from P.violacea and 
X.zambesiaca extracts. 
 
The following appropriate conclusions were drawn on the basis of experimental data: 
the null hypothesis was accepted for objectives number 2: P.violacea and 
X.zambesiaca extracts have anti-mutagenic properties, 4: X.zambesiaca plant 
extract does not have antibacterial activity, 5: P.violacea and X.zambesiaca plant 
extracts have phytochemicals, and 6: P.violacea and X.zambesiaca plant does not 
have bioactive compound. The null hypothesis was rejected for objectives number 1: 
P.violacea and X.zambesiaca plant extracts do not have anticancer activity, 3: 
P.violacea and X.zambesiaca plant extracts have antibacterial activity and 4: 
P.violacea plant extract does not have antioxidant activity. 
 





Cancer is one of the most prominent diseases in humans. Plants remain a prime 
source of drugs for the treatment of cancer and can provide leads for the 
development of novel anticancer agents. Bacterial infections and autoimmune 
response leading to chronic inflammation have been associated with carcinogenesis 
(De Nunzio et al., 2011). One of the most important contributions to the development 
of cancer is oxidative damage to DNA (Fang et al., 2012). Permanent genetic 
alterations may occur in cells where DNA is damaged and where division of this DNA 
occurs before it can be repaired. These cells may begin to divide more rapidly and 
result in carcinogenesis (Reddy et al., 2003). The radical scavenging properties of 
antioxidants are known to eliminate and prevent the generation of free radicals. 
These properties have been contributing directly or indirectly to the prevention of 
pathogenesis and carcinogenesis (Ferrari and Torres, 2003), whereas the ability of a 
plant extract to kill or inhibit the growth of microorganisms is of interest for the 
development of antimicrobial agents. A deleterious effect of radiation is the 
production of reactive oxygen species, which include superoxide anion (O2 
_, a free 
radical), hydroxyl radical (•OH), and hydrogen peroxide (H2O2) (Fang, 1991). These 
reactive species may contribute to radiation-induced cytotoxicity.  
 
The pace of research in the continuing discovery of new anticancer agents from 
natural product sources has been staggering lately (Kinghorn et al., 2003). Along 
with determination of the pharmacological properties of plant extracts, studies on the 
toxicity properties of plant extracts are indispensable to assure the safety of the 
extract (Deciga-Campos et al., 2007). In frequently reported studies, polyphenols 
have been suggested as responsible for potent biological activities of extracts 
prepared using methanol and ethanol (Michielin et al., 2009). The quantification of 
phenolic content by folin ciocalteu reagent and characterization of the extract by LC-
MS were carried out in this study. This study was intended to demonstrate the 
pharmacological activity of P.violacea and X.zambesiaca against cancer-inducing 
factors in order to determine the ability of these plant extracts as possible novel 
anticancer drugs. 
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9.2 SUMMARY OF RESULTS 
 
Analysis P.violacea X.zambesiaca 
Anticancer activity Negative results Negative results 
Antimutagenicity 
activity 
Not mutagenic Not mutagenic 
Antibacterial activity Negative results Negative results 





alkaloids and cardiac 
glycoside 
Flavonoids, saponins, 
terpenoids and cardiac 
glycoside 
Fingerprinting 9 compounds 
identified 
7 compounds identified 
Radioprotection 
effect 
---- It is a radioprotector 
Table 9.1: Summary of all experimental results obtained from this research project. 
 
9.3 HOLISTIC DISCUSSION 
 
P.violacea and X.zambesiaca extracts have been used as traditional medicine for a 
variety of diseases and their safety needs to be determined. For mutagenicity 
testing, the bacterial strains used were the histidine-requiring Salmonella 
typhimurium tester strains and TA100 without metabolic activation. Strain TA98 gives 
an indication of frame-shift mutations, while strain TA100 indicates base-pair 
substitution. According to our results, neither P.violacea nor X.zambesiaca was 
mutagenic in the salmonella/ microsome tester strain TA 100 and TA98. Therefore at 
this moment we can say both plants do not induce mutation, but this test must also 
be performed with metabolic activation to declare these extracts 100% safe and not 
toxic. 
 
It was demonstrated that in vitro antimicrobial activity is dependent upon various 
intrinsic and extrinsic factors, such as molecular weight, degree of deacetylation, 
viscosity, solvent, pH, test strains, temperature (Raafat & Sahl, 2009). Other 
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antimicrobial activity analysis might produce different results because the polarity of 
the natural compounds can affect the diffusion of compounds onto the culture 
medium. Compounds with less polarity diffused more slowly than more polar ones 
(Moreno et al., 2006). The advantage of broth microdilution when compared with the 
agar-based method is that broth microdilution can decrease much labor and time. 
However, limitations of the broth microdilution method are primarily associated with 
the lack of or poor growth of many anaerobic microorganisms. Testing some 
fastidious anaerobes gives inconsistent and unreliable results because of poor 
growth of strains due to excessive exposure to oxygen during the set-up procedure 
(CLSI, 2009).  
 
The ability of P.violacea and X.zambesiaca extracts to inhibit the growth of selected 
bacterial strains was evaluated by using the broth microdilution method. In the broth 
microdilution method, microbial growth was indicated by the presence of reddish-
pink color after the addition of tetrazolium salt. The lowest concentration of extract 
inhibiting growth of test inhibition concentration (MIC) was determined. The MIC 
value indicates the antimicrobial property of an extract. Extract with MIC < 1 mg/ml is 
regarded as exhibiting activity (Seyoum et al., 2006). It was found that methanolic 
extracts of both P.violacea and X.zambesiaca are weak inhibitors of the selected 
bacterial strains, as all micro-organisms managed to grow in the presence of these 
extracts at a concentration above 1.0 mg/ml. Thus the extracts were regarded as not 
active against those bacteria. It is known that in most instances, gram positive 
bacteria are more susceptible to plant extracts than gram negative ones; however, 
this was not the case, as both gram positive and gram negative bacteria were 
resistant. 
 
Antioxidants are the compounds that terminate the attack of reactive species such as 
free radicals and prevent ageing and different diseases associated with oxidative 
damage inside the body system (Rice-Evans et al., 1996). These free radicals can 
oxidize biomolecules, i.e. nucleic acids, proteins, lipids and DNA, cause tissue 
damage and initiate degenerative diseases. Oxidative damage plays a significantly 
pathological role in human diseases such as cancer, emphysema, cirrhosis, 
atherosclerosis and arthritis etc. (Niki et al., 1994). Almost all organisms are 
protected to some extent from free radical (peroxide, hydro-peroxide or lipid peroxyl) 
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damage. Antioxidant supplements or dietary antioxidants may be sources of 
protection that the body needs to protect it against the damaging effects of free 
radicals. Advantages of the DPPH assay are that the test is simple and rapid and 
needs only a spectrophotometer and a dark room to perform, which probably 
explains its widespread use in antioxidant screening. DPPH is a stable nitrogen 
radical that bears no similarity to the highly reactive and transient peroxyl radicals 
involved in lipid peroxidation. Many antioxidants that react quickly with peroxyl 
radicals may react slowly or may even be inert to DPPH owing to steric 
inaccessibility. DPPH is decolorized by reducing agents as well as H transfer, which 
also contributes to inaccurate interpretations of antioxidant capacity.  
 
Various researchers have used the scavenging effect of a chemical on DPPH radical 
as a quick and reliable parameter to assess the in vitro antioxidant activity. From the 
reaction of the extracts with DPPH radical, it was observed that the scavenging 
activity of both extracts was concentration-dependent (Chapter 5). The concentration 
of X.zambesiaca required to scavenge 50% of DPPH radical present in the reaction 
mixture (SC50) was higher compared to P.violacea, but lower when compared to 
ascorbic acid. Methanolic extract of P.violacea scavenges 50% of DPPH radical at a 
concentration of greater than 2.5 mg/ml, while methanolic extract of X.zambesiaca 
scavenges 50% of DPPH radical at a concentration of 2.5 mg/ml. In comparison with 
ascorbic acid, which showed high activity with SC50 (68.5%) from a concentration of 
0.313 mg/ml, both extracts‘ activity was found to be low. 
 
Studies have shown that dietary phytochemical antioxidants are capable of removing 
free radicals. Among them, phenolic and polyphenolic compounds, such as 
flavonoids and catechin in edible plants, exhibit potent antioxidant activities (Decker, 
1995; Fang 2002). The phytochemical screening results in Chapter 6 revealed the 
presence of tannins, flavonoids, steroids, terpenoids, alkaloids and cardiac 
glycosides from P.violacea (leaves, flowers and twigs) extract, while X.zambesiaca 
(leaves, flowers and twigs) extract showed the presence of flavonoids, saponins, 
terpenoids and glycosides. Recently, intensive research has been focused on 
developing tumor therapies from saponins. X.zambesiaca extract contained 
saponins and glycosides. Saponins exhibit potent anticancer activity in several 
human cancer cells through apoptosis-inducing pathways (Kaskiw et al., 2009) and 
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glycosides are compounds that strongly influence the anticancer activity of the plant 
extracts (Yan et al., 2009). However, even though X.zambesiaca contained 
saponins, it was unsuccessful at abolishing selected cancer cells. These results did 
not make sense, unless there was a compound present in the extract that 
suppressed the activity of saponins against cancer cell lines. Further investigations 
are required in future to elucidate this occurrence. 
 
The objective of the identification of phenolic compound present in these plant 
extracts was to have an idea of what they comprise so that one can fractionate and 
obtain pure compounds in amounts sufficient for further analysis in future studies. 
LC-MS results confirmed the total phenolic content of both these plants, as we 
identified a correlation between the estimated total phenolic content and a number of 
compounds identified. X.zambesiaca had seven active compounds identified using 
LC-MS and less estimated total phenolic content when compared to P.violacea, 
which had a high estimated total phemolic content and nine active compounds 
identified. The presence of flavonoids detected in P.violacea was expected, because 
this class of secondary metabolite is a conspicuous constituent of species belonging 
to the Fabaceae family (Hertog et al., 1993; Yen et al. 1996), which proved that 
methanol is the most suitable solvent for extraction of phenolic compounds. 
 
Antioxidant polyphenols have radiomodulatory properties that are radioprotecting in 
respect of non-cancerous cells while radiosensitizing tumor cells. This dual action 
may be the result of their radical scavenging properties and their effects on cell-cycle 
checkpoints that are activated in response to radiation-induced chromosomal 
damage. It could also be caused by their effect on regulatory pathways, affecting 
detoxification enzymes, the up-regulation of endogenous protective systems and 
cell-cycle-dependent processes of DNA damage. This part of the work was aimed at 
elucidating the free radical scavenging features of X.zambesiaca as a radioprotector. 
P.violacea was not assessed for its radioprotective effect, as it had low free radical 
scavenging potential. Based on the clonogenic assay, the cell surviving fractions for 
DU145 at 2 Gy with and without X.zambesiaca were found to be 0.23 ± 0.13 and 
0.15 ± 0.10, respectively. The corresponding RPF value emerged as 1.53 ± 0.57, 
indicating that X.zambesiaca extract can lead to over 50% reduction in cell death. 
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This confirmed the free radical scavenging features of the extract and suggested that 
it might be useful as a radioprotector. 
 
9.4 HOLISTIC CONCLUSION 
 
Both P.violacea and X.zambesiaca can be considered safe to be used in view of the 
evidence obtained through antimutagenic activity with no metabolic activation 
analysis. The methanolic leaf, twig and flower mixture of these plants extracts was 
for the first time reported to contain tannins, flavonoids, steroids, terpenoids, 
alkaloids and cardiac glycoside. Nevertheless, both extracts did not have in vitro 
anticancer activity against breast (MCF7), colon (HCT116), renal (UACC-62), 
melanoma (TK-10) and prostate (PC3) cancer cell lines and also did not have the 
potential to inhibit the growth of Staphylococcus aureus, S. epidermidis, S. 
saprohyticus, Bacillus subtilis, Enterobacter cloacae, Escherichia coli and 
Pseudomonas aeruginosa (clinical strains). X.zambesiaca showed moderate 
antioxidant activity and over 50% reduction in cell death of prostate cancer cells 
when exposed to radiation. These results confirmed its ability to scavenge free 
radicals and the radioprotective effect of this plant extract. It was also shown that 
P.violacea has low antioxidant potential (ability to scavenge free radicals), thus, the 
radioprotective effect of this plant extract was not explored, as there was no need to 
do this. A number of phytochemicals and the estimated total phenolic content were 
higher than in X.zambesiaca, with nine compounds identified, of which two are 
unknown. Seven compounds were identified in X.zambesiaca and this correlated 
with the estimated total phenolic content. 
 
9.5 LIMITATIONS OF THE STUDY 
 
 It was not possible to do this study using human subjects, as the test plants have 
not been used in animal models and clinical trials yet. 
 It was not possible to test the plant extracts against a larger number of tumor cell 
lines and bacterial strains at this stage owing to limited resources and time. 
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 It was not possible to analyze the activity of each and every part of the plant, as 
the extract was already mixed as per ethnobotanical instructions. 
 It was financially challenging to obtain plant extracts from different geographical 
areas, as this requires transport and the correct timing of these plants‘ blooming 
period. 
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“Recommendations for further research” 
This study was intended to contribute to the knowledge base of the anticancer 
therapeutic potential of P.violacea and X.zambesiaca. It should be noted that plant 
material used in this study was received from the University of the Free State and 
their preparation (mixture of twigs, flowers and leaves) was based on ethnobotanical 
claims made by cancer-treating traditional healers they consulted. Our chosen plants 
were randomly selected from 60 plants belonging to the Fabaceae family. Since 
other compounds are extracted better with different solvents because of the 
differences in polarity, extraction using a variety of solvents could have 
demonstrated a vast difference as far as the experimental results are concerned. 
Furthermore, to account for possible geographical and chemotypic variations, plant 
material should be studied from several populations in the future. 
I. Anticancer 
 This study has shown that P.violacea and X.zambesiaca do not have potential 
anticancer activity in vitro against breast (MCF7), colon (HCT116), renal (UACC-
62), melanoma (TK-10) and prostate (PC3) cancer cell lines using the 
Sulforhodamine B (SRB) assay. Previous studies have shown the presence of 
isoflavones from X.zambesiaca and we have also identified the existence of this 
compound.  
 Firstly, we will recommend the analysis of anticancer activity of these extracts on 
other cancer cell lines, such as the ovarian cancer cell line.  
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 Secondly, activity-guided fractionation, isolation and identification of identified 
compounds are imperative, as these may lead to the development of novel 
treatments in the global struggle against cancer and cancer-related ailments. 
II. Mutagenicity 
 The crude P.violacea and X.zambesiaca extracts were observed to be non-toxic. 
However, the risk assessment of these extracts will not be complete unless they 
are tested for promutagenic and comutagenic effects. 
 It is important to note that in order to establish a toxicity profile, other cell lines 
should be investigated, such as liver HepG2 cells (for metabolic activation), as 
well as in vivo studies.  
III. Antimicrobial activity 
 In this study, it was apparent that P.violacea and X.zambesiaca did not have the 
potential to inhibit the growth of Staphylococcus aureus, S. epidermidis, S. 
saprohyticus, Bacillus subtilis, Enterobacter cloacae, Escherichia coli and 
Pseudomonas aeruginosa through a variety of concentrations when using broth 
microdilution assay.  
 The concentration of compounds within each of the species must be determined, 
as well as whether synergistic, antagonistic or additive effects occur.  
 Other types of antimicrobial activity assay can be undertaken, such as disk 
diffusion, as some limitations of the broth microdilution method are primarily 
associated with the lack of or poor growth of many anaerobic microorganisms. 
Some micro-organisms used were facultative anaerobes.  
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IV. Anti-oxidant activity 
 No single testing method is capable of providing a comprehensive profile of the 
antioxidant capacity of a plant species, because of the complexity of oxidation-
anti-oxidation processes, and therefore different methods are to be used to 
determine the anti-oxidant potential. 
V. Phytochemical investigation 
 It is recommended that a thorough geographical variation study be performed on 
each species to explain the diversity between individuals within a population and 
between populations. 
 Quantitative results obtained about the presence of compounds from these plants 
warrant further study, such as purification and then LC-MS, as the LC-MS on 
crude extract gave a tentative identification of molecules only.  
 After purification, further analysis must be conducted using different detectors 
and chromatographic techniques in order to obtain the quantity of the 
compounds. 
VI. Isolation and identification of compounds 
 Isolation and structural elucidation of the compound/s responsible for the 
antioxidant activity of X.zambesiaca should be thoroughly investigated.  
 The presence of these active compounds can be determined by isolating and 
repeating the compounds‘ identification process, but now with the pure and 
targeted compounds, with the guidance of compounds identified under 
phytochemical screening analysis.  




 X.zambesiaca was found to protect prostate cancer cell lines against radiation, 
thereby contributing to the overall radioprotective activity. However, isolation of 
the active principle(s) responsible for the observed radioprotection, correlation of 
pharmacokinetics with dynamics and the evaluation of mechanisms of 
radioprotection will need to be pursued further. 
 The antioxidant activity of the investigated compounds in this study must be 
compared with their radioprotective properties to demonstrate a correlation 
between the radioprotective activity of the phenolic glycosides and their 
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